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Thiol-disulfide redox homeostasis is integral for maintaining the redox status of 
proteins and other thiol-containing molecules within cells. Mitochondria are particularly 
vulnerable to disruptions in redox balance, due to production of reactive oxygen species 
(ROS) during oxidative metabolism. Among the many antioxidants and detoxifying 
enzymes existing in mitochondria, glutathione (GSH) has proven to be critical for the 
preservation of function and structural integrity of the organelle. Therefore, our studies are 
aimed at elucidating the factors that control mitochondrial GSH metabolism in the model 
eukaryote Saccharomyces cerevisiae (baker’s yeast). A critical component of 
understanding subcellular GSH homeostasis is identifying routes of entry into the 
organelle. Using genetic modifications combined with targeted redox-sensitive green 
fluorescent protein-based probes, previous studies found that GSH enters the mitochondrial 
intermembrane space (IMS) through porins located in the outer mitochondria membrane 
via passive diffusion. These studies demonstrated that reduced (GSH) and oxidized 
glutathione (GSSG) pools of the cytosol and IMS are interconnected. On the contrary, the 
GSH redox potential (EGSH) of the mitochondrial matrix was found to be separate from that 
of the cytosol. While attempts have been made to uncover a mitochondrial GSH/GSSG 
importer, none have been confirmed with certainty. Our current studies are aimed at 
identifying a mitochondrial transporter specific for GSH and biological processes that 
affect mitochondrial GSH/GSSG pools. Furthermore, we tested the effects of GSH and
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GSSG overaccumulation on the mitochondria of yeast cells overexpressing the high 
affinity GSH/GSSG transporter, Hgt1. We also explored the possibility that plasma 
membrane-localized Hgt1 exhibits dual localization to the mitochondrial membrane. We 
find that HGT1 overexpression in strains incubated with GSH and GSSG leads to GSH and 
GSSG accumulation in mitochondria as well as the cytosol. However, Hgt1 does do not 
appear to be localized to mitochondria. Intercompartmental cross-talk is also thought to 
regulate subcellular GSH:GSSG pools. Therefore, we investigated if vacuolar storage of 
excess GSH could affect mitochondrial GSH concentrations. Our subcellular GSH 
measurements imply that HGT1 overexpression affects mitochondrial GSH pools and the 
vacuole acts as a buffering compartment during GSH and GSSG overaccumulation.  
The physiological role of GSH depletion on cellular function and subcellular redox 
status has been well characterized. Mitochondrial GSH has been reported to be critically 
important because of its roles in redox homeostasis and iron metabolism. High intracellular 
GSH has also been shown to be toxic to cells, yet it has not been determined how cells 
depleted of GSH (gsh1∆) respond to increased GSH uptake. To study this, we employed a 
gsh1∆ yeast strain engineered to overexpress HGT1.  Interestingly, our results show that 
HGT1 overexpression alone can partially rescue growth in cells devoid of GSH and reverse 
some of the iron-related phenotypes. We demonstrate that cysteine is a key amino acid for 
rescue, suggesting that cysteine may partially substitute for GSH in gsh1∆ cells.  However, 
we did not find significantly increased cysteine levels in HGT1 overexpressing strains, 
leaving open the specific mechanism whereby HGT1 overexpression compensates for the 
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INTRODUCTION AND SCOPE OF THESIS  
Thiol Redox Pathways/Regulation  
Thiol redox biochemistry is assumed to play a pivotal role in understanding cellular 
processes such as oxidant-dependent signaling and cell fate decisions (1). Oxidants in the 
form of reactive oxygen species (ROS) have potentially toxic effects and are linked to 
neurodegenerative disorders, aging, and cancer (2). To prevent hyper-oxidation, cells 
depend on the concerted efforts of antioxidants and detoxifying enzymes (3). For instance, 
the thioredoxin (TRX) and glutathione (GSH)/ glutaredoxin (GRX)  pathways are 
conserved thiol-reductase systems that maintain cellular redox homeostasis via disulfide-
exchange reactions (4). TRXs and GRXs are small oxidoreductases (usually 9-15 kDa) of 
the Trx-fold oxidoreductase superfamily that reduce disulfides via the CXXC cysteine 
(Cys) residues in their active sites. TRXs donate electrons to reduce protein disulfides 
resulting in oxidation of the CXXC active site. Oxidized TRXs are reduced back to the 
dithiol form by the flavoenzyme TRX reductase (TRR) using NADPH as a reducing 
equivalent.  GRXs are also capable of catalyzing the reduction of disulfide-oxidized protein 
substrates or GSH mixed disulfides. GSH also serves as a reducing agent and cofactor for 
oxidized GRXs. Oxidized GSH (GSSG) is reduced and regenerated to GSH by GSSG 










Figure 1.1 Thiol-Disulfide Redox Systems.  Model illustrating the TRX and GSH/GRX 
redox regulatory pathways. TRR= TRX reductase, GLR= GSSG reductase.   
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The first TRX discovered was isolated from E. coli and identified as an electron 
donor for ribonucleotide reductase, the enzyme providing deoxyribonucleotides for DNA  
replication (7). In later studies involving mutants lacking TRXs, GRXs were also found to 
effectively reduce ribonucleotide reductase. Cells rely on ribonucleotide reduction for not 
only DNA synthesis but also sulfate reduction to generate reduced sulfur in the form of 
cysteine and reduction of methionine sulfoxide (8, 9).  Further research revealed that the 
biological activities in which TRXs and GRXs are involved have grown considerably 
beyond DNA replication. 
TRX and GRX share a very similar structural identity and are conserved throughout 
evolution. The TRX protein family is defined by a structural motif named the TRX fold 
which consists of four stranded β-sheets flanked by three α-helices on either side of the β-
sheets (Fig. 1.2) (7, 9). Proteins within the TRX family share a common Cys-X-X-Cys 
active-site motif. Interestingly, amino acids between the two cysteines vary between the 
TRX and GRX proteins. The active site motif of TRXs is Cys-Gly-Pro-Cys, whereas GRXs 
are subdivided into two subfamilies: dithiol and monothiol GRXs. Dithiol GRXs contain 
Cys-Pro-Tyr-Cys or Cys-Pro-Phe-Cys active site motifs and monothiol GRXs have a Cys-
Gly-Phe-Ser motif. Despite variations in the active sites, monothiol and dithiol GRXs share 
the TRX-fold structure (10, 11). 
The primary role of the TRX or GSH/GRX pathways in E. coli  is their involvement 
in ribonucleotide reduction (12). TRX and GRX functionally overlap in prokaryotes. 
Therefore, E. coli is viable if either pathway is deleted while inactivation of both pathways 










Figure 1.2 TRX fold proteins architecture. β-sheet strands are depicted as arrows and α-
helices as rectangles. The dashed lines indicate separation of the fold into N-terminal (βαβ) 
and C-terminal (ββα) motifs which are connected by the α2 helix (14).  
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cytosol and mitochondrial matrix. The cytosolic TRX pathway consists of two TRX 
isoforms (Trx1 and Trx2) and a TRR (Trr1). The mitochondrial matrix contains a TRX 
(Trx3) and TRR (Trr2). Similarly, the cytosolic GSH/GRX pathway is comprised of two 
dithiol GRXs (Grx1, Grx2) and GLR (Glr1). In the mitochondrial matrix, there exists Glr1 
and Grx2. Dual localization of Glr1 and Grx2 to the cytosol and mitochondria is due to an 
alternative start site upstream of the canonical one, thereby creating a N-terminal 
mitochondrial targeting sequence (15–17). Inactivation of Glr1 together with cytoplasmic 
TRXs or with Trr1 in yeast is synthetically lethal (18, 19). On the contrary, deletion of both 
cytoplasmic TRXs or the dithiol GRXs does not affect viability. Yeast containing a single 
gene deletion of the gene encoding γ-glutamylcysteine synthetase (GSH1), the rate-limiting 
enzyme in GSH biosynthesis, are unable to survive without GSH supplementation (20). 
This essential nature of GSH in yeast and higher organisms has made determining its 
contribution to thiol-redox control challenging and thus the primary function of GSH has 
been a topic of debate (12). 
 
Biosynthesis and Regulation of GSH  
 GSH is the most abundant small intracellular thiol (–SH) molecule in eukaryotic 
cells. Its high intracellular concentration (between 3 and 10 mM) and negative redox 
potential (−240 mV) enables GSH to provide reducing capacity for a number of biological 
reactions (21, 22). As an antioxidant,  GSH serves as an electron donor for GSH 
peroxidases that detoxify hydrogen peroxide by catalyzing its reduction to water (23). 
Furthermore, glutathione S-transferases (GSTs) are able to rid the cell of xenobiotics by 
forming GSH-dependent conjugates (24). In addition to its function as a thiol-redox buffer, 
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GSH is involved in iron-sulfur (Fe-S) cluster biogenesis, redox signaling, apoptosis, and 
metabolism of heavy metals (25, 26).  
GSH is synthesized in the cytosol from the amino acids glutamate, cysteine, and glycine 
via two conserved ATP-dependent steps catalyzed by the enzymes γ-glutamylcysteine 
synthetase (Gsh1) and GSH synthetase (Gsh2) (27). In the first step, cysteine and glutamate 
are linked by Gsh1 to form γ-glutamylcysteine. The first reaction is the rate-limiting step 
and is regulated by cysteine availability. GSH is formed in the second reaction by Gsh2, 
which covalently links glycine to γ-glutamyl-cysteine (Fig. 1.3) (28). While GSH is only 
made in the cytosol, its functions are required in other organelles such as the nucleus, 
endoplasmic reticulum, and mitochondria. In the nucleus, GSH maintains the redox state 
of critical protein sulfhydryls involved in DNA repair and expression, and functions as a 
hydrogen donor for ribonucleotide reductase as mentioned previously (29). GSH is also 
found in the ER and mitochondrial intermembrane space (IMS) where thiol-containing 
proteins are oxidatively folded by disulfide oxidases and members of the protein disulfide 
isomerase (PDI) family. In these compartments, GSH is thought to function in disulfide 
proofreading by reducing mismatched disulfide bonds to ensure proper oxidative folding 
of imported proteins (30–33). Fe-S cluster biogenesis within the mitochondrial matrix also 
relies on distinct GSH pools within the organelle (34, 35).  Variations in GSH requirement 
in each organelle is accompanied by differences in total GSH concentration and the reduced 
to oxidized ratio. For instance, the GSH:GSSG ratio in the endoplasmic reticulum (ER) is 
<7:1 suggesting that the ER is relatively oxidizing (36). On the contrary, the cytosol and 
nucleus are very reducing with a GSH:GSSG ratio of 3000:1, while the mitochondrial 









Figure 1.3 GSH biosynthesis pathway. GSH is synthesized in the cytosol via a two-step 
ATP-dependent enzymatic process. In the first step, γ-glutamylcysteine is formed by γ-
glutamylcysteine synthetase (Gsh1). In the second step, glycine is added to the peptide via 
GSH synthetase (Gsh2).   
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Subcellular Distribution of GSH 
Intracellular GSH pools are composed of GSH that is either synthesized in the 
cytosol or imported from the extracellular environment. Therefore, distribution of GSH to 
subcellular compartments is thought to occur through permeable pores and GSH-specific 
transporters. Targeted fluorescent probes genetically engineered to equilibrate with GSH 
have made it possible to study redox control pathways and transport into organelles. Hu 
and coworkers were the first to look at GSH equilibration between the cytosol and IMS of 
yeast. In this study, they used a redox-sensitive yellow fluorescent protein (rxYFP) 
localized to the IMS. They discovered that the GSH:GSSG redox potential (EGSH) 
measured by  IMS-rxYFP (-255 mV) is distinct from redox measurements in the cytosol (-
286 mV) and mitochondrial matrix (-296 mV), since it was more oxidized than the other 
compartments (37). A subsequent study demonstrated that the oxidizing environment 
previously measured in the IMS is due to limiting amounts of GRXs available to catalyze 
equilibration of GSH with IMS disulfides (38). Evidence of GSH permeation via pores in 
the outer mitochondrial membrane (OMM) was later established by Kojer et al. The authors 
also used a redox-sensitive fluorescent protein (roGFP2) targeted to the IMS; however, in 
this study human Grx1 was fused to roGFP2 to facilitate rapid equilibration with local 
GSH:GSSG pools. By monitoring the dynamic changes in EGSH of cells that were exposed 
to oxidants which were subsequently removed, they were able to explore interplay between 
subcellular compartments. They found that GSH pools of the IMS equilibrate with the 
cytosol. Furthermore, evidence for the role of porins in mitochondrial GSH import was 
found using strains lacking Por1 (por1∆). The OMM contains two porins, Por1 and Por2. 
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Deletion of Por1, the predominant isoform, caused the IMS GSH redox pool to be more 
oxidized and therefore no longer in equilibrium with the cytosol (39).  
Free diffusion of GSH from the cytosol to the nucleus is thought to occur via the 
nuclear pore complex. The connections between cytosolic and nuclear GSH was establish 
in plant Arabidopsis thaliana. It was discovered that GSH was recruited to the nucleus 
during G1 phase of cell growth. The accumulation of GSH in the nucleus is, therefore, 
critical for cellular proliferation (40, 41). Increased GSH in nucleus was also linked to 
severe depletion of cytoplasmic GSH pools (40). In mammalian cells, the anti-apoptotic 
protein Bcl2, which promotes cell survival, has been identified as a candidate GSH-
recruiting protein to the nuclear envelope. Bcl2 was suggested to form a pore-like structure 
which may be responsible for GSH sequestration to the organelle (41, 42). 
 
GSH Transporters  
 The transport of GSH across many different membranes within a variety of 
organisms has been well documented. However, only a few GSH transporters have been 
identified. The first known GSH transporters were the mammalian multidrug resistance 
protein and yeast Ycf1 belonging to the ATP-binding cassette (ABC) transporter 
superfamily. The proteins were found to efflux excess GSH out of the cytoplasm at the 
plasma membrane of mammalian cells and vacuolar membrane in S. cerevisiae, 
respectively (43, 44). These transporters have a broad range of substrates and a relatively 
low affinity for GSH with a Km of approximately 15 mM (45, 46). Furthermore, they were 
shown to facilitate excretion from the cytosol and subsequent degradation of GSH and 
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GSSG (45). Thus, the first identification of proteins that transport GSH, although with low 
affinity, were not representative of GSH uptake.  
More recently, a yeast genomic search for candidate GSH transporters in S. 
cerevisiae led to the discovery of the plasma membrane-localized Hgt1/Opt1 as the first 
high affinity GSH transporter. Hgt1 belongs to a novel and structurally 
uncharacterized oligopeptide transporter (OPT) family. The OPT family of transporters are 
known to mediate the uptake of tetra- and pentapeptides such as endogenous opioids 
leucine enkephalin (Tyr-Gly-Gly-Phe-Leu) and methionine enkephalin (Tyr-Gly-Gly- 
Phe-Met). However, the affinity for these peptides was relatively low, with a Km = 310 μM 
compared to reduced GSH (Km = 54 μM) and oxidized GSSG (Km = 91 μM). Homologues 
of Hgt1 can be found in fungi, plants, bacteria, and archaea. The importance of GSH 
transport across the plasma membrane of mammalian cells has been established, yet no 
Hgt1 human homologues have been identified (47–49).   
Many structural and mechanistic aspects of members of the OPT family are 
unknown. However, the dependency of the OPT members on proton-coupled transport has 
been established. In efforts to identify the substrate binding residues of Hgt1, an alanine 
scanning mutagenesis of polar or charge residues was done in the putative transmembrane 
domain. This study revealed four transmembrane domains (TMD1, TMD4, TMD9, 
TMD12) and a proline rich intracellular loop (537-568) that are critical for GSH transport. 
Residues N124 of TMD1, Q222 of TMD4, Q526 of TMD9 and K562 of the intracellular 
loop were found to directly or indirectly interact with GSH. A later analysis of resides 
important for substrate recognition revealed that both Q526 and F523 of TMD9 are 
required. Both resides are also conserved among OPT members known to uptake GSH 
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(50). Characterization of Hgt1 has been an important step as it provides a model for how 
transporters bind and transport GSH across membranes (51). 
Intercompartmental transport of GSH and GSSG is hypothesized to be a key 
contributor to the regulation of GSH homeostasis in subcellular compartments. Therefore, 
many studies have been designed to explore factors that influence organelle specific GSH 
pools and identify subcellular transporters. For instance, Ycf1 has been known to help 
regulate cytosolic GSH:GSSG ratio by sequestering excess GSSG to the vacuole that has 
not been reduced by thiol-reductase systems (52). A second vacuolar GSH transporter Bile 
pigment transporter 1, Bpt1, has been identified in S. cerevisiae. This protein has a higher 
affinity for GSH (Km = 3 mM) compared to Ycf1 (Km =15 mM). Yet, Bpt1 is less capable 
of transporting GSH (53). Glutathione Exchanger (Gex1) and its paralogues Gex2 are 
confirmed GSH transporters belonging to the Aft1 regulon (ARN) family. Gex1/2 are 
mostly at the plasma membrane in early exponential growth phase and at the vacuolar 
membrane in late exponential phase. When on the plasma membrane, Gex1/2 mediates 
cytosol acidification and the expulsion of GSH. The authors hypothesized that the lower 
pH in the cytosol induces the targeting of Gex1 to the vacuolar membrane resulting in GSH 
import and export of H+. Unlike other members of the ARN family, Gex1/2 are not 
regulated by the activator of ferrous transport protein 1 (Aft1). Instead, the transporters are 
regulated by its paralog Aft2. Gex1/2 also differ from members of the ARN family because 
they are not involved in the transport of known iron-binding siderophores, but instead 
support GSH intercompartmental exchange (54). Along with Gex1/2, yeast is thought to 
possess another GSH export protein, Gxa1, belonging to the ABC family. The suggestion 
that Gxa1 is a GSH exporter was based on a study showing that overexpression of GXA1 
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leads to a significant increase in intracellular GSH in yeast defective in extracellular GSH 
utilization (55). Another example of how intercompartmental cross-talk could potentially 
affect the subcellular environment can be seen in the Opt2 transporter, a close homolog of 
Hgt1/Opt1. Opt2 was determined to be dually localized to the plasma membrane and 
peroxisomes of yeast. Interestingly, Opt2 was found to not only affect cytosolic and 
peroxisomal GSH:GSSG but mitochondrial GSH:GSSG as well (56). 
In reference to other organelles, the endoplasmic reticulum (ER) is more oxidizing 
and early reports suggest that GSSG is selectively imported into the ER luman (30). A 
subsequent study using rat liver microsomal vesicles found that reduced GSH is selectively 
imported into hepatic endoplasmic reticulum while GSSG is virtually nonpermeable. A 
portion of imported GSH is converted into GSSG by the intraluminal oxidation of GSH. 
Interestingly, GSSG generated in the microsomal lumen scarcely exited from the vesicles. 
Therefore, retention of GSSG in the ER may be responsible for an oxidizing environment 
(57). In a recent search to identify a candidate ER GSH transporter, Ponsero et al. screened 
null and temperature-sensitive mutants of genes encoding ER transmembrane proteins. As 
a result, protein-conducting channel Sec61 was found to transport GSH into the ER of S. 
cerevisiae by facilitated diffusion (58). The discovery of an ER transporter has added to 
the list of already identified GSH-specific transporters located in various membranes in S. 
cerevisiae (Fig. 1.4). 
 
Mitochondrial GSH 
Mitochondria are a major source of energy in eukaryotic cells and the primary site 








Figure 1.4. Schematic of known and predicted GSH transporters in Saccharomyces 
cerevisiae. GSH is exclusively made in the cytosol or may be imported from the 
extracellular environment. GSH synthesized and imported in the cytosol must be 
transported into subcellular compartments. The illustration shows known GSH transporters 
and organelles predicted to contain GSH transporters. 
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mitochondria involves four-election reduction of molecular oxygen to water. However, 
incomplete transfer of electrons results in the formation of superoxide anion (O2
•) and 
hydrogen peroxide (H2O2). In addition to the ROS generated during respiration, other toxic 
or pathological conditions can lead to an impairment of mitochondrial function causing an 
increase in ROS. Thus, mitochondria are constantly exposed to potentially damaging 
oxidant species. Yet, the organelle remains functional due to the existence of myriad 
antioxidant enzyme systems such manganese superoxide dismutase (MnSOD), and the 
GSH/GRX and TRX pathways. Collectively, these enzymes and thiol redox systems 
combat deleterious ROS production. Evidence over recent years has demonstrated that 
mGSH is of particular importance in regulating the thiol redox environment (3, 59–61).  
Mitochondrial GSH is mainly found in the reduced state and represents a small 
fraction of the total GSH pool (10–15%). Given the size of the mitochondrial matrix, 
however, the concentration of mGSH is similar to that of the cytosol (10–14 mM) (3). The 
primary form of ROS generated during mitochondrial respiration is superoxide (O2
•), a free 
radical with moderate reactivity. Superoxide can be dismutated to H2O2 by SOD, which is 
the first line of antioxidant defense in the mitochondrial matrix.  H2O2 is a relatively mild 
oxidant. However, in the presence of transition metals such as Fe2+ and Cu+ it can be 
converted into the highly reactive hydroxyl radical (•OH) by the Fenton reaction (62). To 
rid the mitochondria of H2O2, cells rely on GSH peroxidase (Gpx) to rapidly reduce H2O2 
to water using reducing equivalents from GSH. Reduced mGSH becomes oxidized through 
the process of detoxification and is recycled back by the NADPH-dependent GSSG 
reductase (GLR). GSSG is not readily exported out of the mitochondria. Thus, GLR in this 
organelle is critical for maintaining redox homeostasis (63, 64). 
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 Selective depletion of GSH in the mitochondria results in oxidant sensitivity, 
mitochondrial dysfunction, and disruption of iron regulation. Therefore, understanding 
factors that regulate mitochondrial GSH pools and identifying a mitochondrial GSH 
transporter is vital to our understanding of diseases characterized by low mitochondrial 
GSH (mGSH) (35). Evidence for distinct GSH pools in the mitochondrial matrix has 
prompted studies aimed at finding a GSH transporter on the mitochondrial membrane. Two 
members of the superfamily of anion carriers have been identified as potential mGSH 
transporters: dicarboxylate carrier (DIC) and 2-oxoglutarate carrier (OGC). Direct 
evidence of GSH uptake was shown when DIC and OGC were partially purified and 
reconstructed into proteoliposomes. In a separate study, using rat renal mitochondria, the 
transport of GSH by the anionic transporters was found to contribute to approximately 50% 
of observable transport (65, 66). On the contrary, research conducted by Booty et al. was 
unable to confirm GSH transport by OGC and DIC (67). The model used to study transport 
was created by first expressing human OGC and S. cerevisiae DIC in Lactococcus lactis. 
Uptake activity and substrate specificity was then assessed in L. lactis membranes 
containing OGC or DIC proteins that were fused with liposomes. These experiments were 
carried out in a simpler model compared to previous reports where the characterization of 
the individual transport processes can be difficult. Therefore, the authors believe that the 
L. lactis model system is better to explore GSH transport than previous systems because 
observed transport could have been due to secondary consequences of metabolite 
redistribution between the mitochondria and the cytosol (67). Neither of the yeast 
homologues of DIC or OGC has been determined to transport GSH. Therefore, an 








Figure 1.5 Mitochondrial GSH transport. Transport of GSH into the IMS of the 
mitochondria is dependent upon porins in the OMM. Dicarboxylate carrier (DIC) and the 
2-oxoglutarate carrier (OGC) have been established as candidate transporters involved in 
the import of cytosolic GSH inside the mitochondria in mammalian cells but not in yeast 
cells. Modified from a figure generated by C. Outten.
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As stated previously, yeast mitochondria possess a full set of TRX and GSH/GRX 
pathways. Currently, the only known function these pathways have are to assist 
mitochondrial peroxiredoxin (PRX) Prx1 and perhaps Gpx2 in protecting mitochondria 
against respiratory ROS as well as exogenous peroxide (68). GSH fulfills an additional role 
separate from its connection to the thiol-reductive systems, which is its involvement in iron 
metabolism. A recent report provides evidence that the role of GSH in regulating iron 
homeostasis may be the reason for the requirement of GSH for viability (12). 
 
Iron Regulation and GSH Metabolism in Saccharomyces cerevisiae 
 Tight regulation of  intracellular iron levels is important for eukaryotic cells as 
high iron can be toxic due to its role in catalyzing the formation of hydroxyl radicals via 
Fenton chemistry. Yet, it is indispensable for a variety of biological functions as a cofactor 
for several essential proteins such as Fe-S cluster proteins and hemoproteins. A few 
examples of important Fe-S proteins include DNA polymerases, nicotinamide adenine 
dinucleotide (NADH)-dehydrogenases, ferredoxins, and aconitases (26). Hemoproteins 
contain a heme prosthetic group allowing them to carry out oxidative functions. One 
famous example of this is hemoglobin, a protein within red blood cells that is responsible 
for transporting oxygen to tissues. Other important hemoproteins include cytochromes, 
myoglobin, catalases, and peroxidases (69). Therefore, it comes as no surprise that 
disturbances  in  iron  homeostasis or Fe-S cluster biogenesis are linked to many iron-
related dieases such as Parkinson’s disease and anemia (11).  
 Regulation of iron in S. cerevisiae occurs primarily at the transcriptional level via 
the transcription factor Aft1 and its paralog Aft2 (70, 71). The iron sensing proteins 
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regulate iron by controlling iron-responsive genes that are responsible for acquisition, 
compartmentalization, and utilization of iron. Low iron conditions results in Aft1 transport 
from the cytosol into the nucleus where it binds to the conserved promoter sequence motif 
(T/CG/ACACCC) in the 5′-upstream regions of target genes. As a result, expression of 
genes involved in iron uptake (FET3, FTR1, and FRE1,2), siderophore uptake (ARN1-4 
and FIT1-3). and Fe-S cluster formation (ISU1,2) are induced (72–76). Iron-replete 
conditions causes Aft1 to become disassociated from target promoters and translocated 
back to the cytosol by the nuclear exporter Msn5. Aft2 is assumed to function in a similar 
manner due to its close homology to Aft1 (77).   
Iron regulation by Aft1 is impacted by Fe-S cluster biogenesis occurring in the 
mitochondrial matrix of S. cerevisiae. This process happens in two distinct stages. In the 
first step, Fe2+ and sulfur are joined on a scaffold protein (Isu). Sulfur is acquired through 
its release from cysteine by the cysteine desulfurase Nfs1. The function of Nfs1 is 
dependent on its complex with Isd11. Nfs1-Isd11 generates sulfane sulfur (S0) by 
persulfide formation. For Fe-S cluster synthesis to occur, sulfur (S0) must be reduced to 
sulfide (S2−) (78). This reduction is thought to occur in yeast via electron transfer by the 
ferredoxin-ferredoxin reductase pair Yah1 and Arh1 using electrons from NADPH (79–
81). Yfh1, the yeast homologue of human frataxin, is proposed to deliver iron to the Isu 
protein (82). In the second stage, a chaperone helps release the newly synthesized Fe-S 
cluster from the scaffold and assist in its binding to the ISC transfer protein Grx5 (83). The 
synthesis of cytosolic and nuclear Fe-S proteins is dependent on the mitochondrial export 
of a still unknown compound via the mitochondrial inner membrane transporter Atm1 (84).  
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 Direct links between iron metabolism and thiol-redox metabolism have been 
established in various reports. For instance, GSH polysulfide (GS-S-SG) has been 
identified as a substrate for Atm1. This discovery suggests that GSH may be involved in 
extramitochondrial Fe-S cluster assembly by assisting in the transport of activated 
persulfide (S0) from the mitochondria to the cytosol (34). Additionally, depletion of GSH 
leads to constitutive activation of the Aft1/2 iron regulon and disruption in the synthesis of 
extramitochondrial Fe-S clusters (12, 85). This effect is also seen in strains lacking Atm1 
(85). Interestingly, Kumar et al. found that toxic levels of GSH in yeast cells leads to Aft1 
accumulation in the nucleus and inhibits cytoplasmic Fe-S cluster maturation. Therefore, 
maintaining intracellular GSH levels is critical for cytosolic Fe-S-containing proteins. 
Monothiol GRXs, Grx3 and Grx4, localized in the cytosol have also been identified 
as regulators of Aft1 activity and Fe-S cluster biosynthesis. The dissociation of Aft1 from 
its target promoters under iron-replete conditions was found to be dependent on its 
interaction with Grx3 and Grx4 (11). Ueta et al. reported that binding of Grx3 and Grx4 to 
an Fe-S cluster is a prerequisite for interactions with Aft1. The Atm1 transporter was also 
determined to be necessary for iron binding to Grx3 and dissociation of Aft1 from its target 
promoters (86). Using a genetic screen to find mutants than were involved in iron 
regulation, Kumánovics et al. discovered two unexpected cytosolic proteins, Fra1 and Fra2, 
that when deleted activated the iron regulon. Fra1 and Fra2 were shown to bind Grx3 and 
Grx4 in an iron-dependent manner. This complex inhibits Aft1 from entering the nucleus. 
Individual deletions of Fra1/2 or Grx3/4 causes Aft1 to be constitutively active and thereby 
nuclear localized (87–89).   
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The connection between Fe-S clusters biogenesis and Aft1 regulation has been well 
established. However, it was not until a study conducted by Poor et al.  that the molecular 
mechanism for such regulation was unveiled. In this study, a crystal structure of Aft2 bound 
to DNA revealed a Zn finger motif that was essential for DNA binding. In addition, an 
[2Fe-2S] cluster was shown to bind Aft2 at the conserved CDC motif leading to its 
dimerization. Using UV-visible absorption and circular dichroism spectra, the authors were 
able to show that Aft2 receives a [2Fe-2S] cluster via direct Fe-S cluster transfer from [2Fe-
2S]-bridged Grx3-Fra2 heterodimers. This study also revealed that the [2Fe-2S]-bridged 
Aft2 homodimer has a lower DNA binding, resulting in deactivation of the iron regulon. 
Collectively, these findings have allowed researchers to develop a mechanism for Aft1 
regulation by Fe-S cluster biogenesis and a proposed model for iron regulation in S. 
cerevisiae has been created (Fig. 1.6) (90).  
Molecular and genetic manipulation of yeast has proven to be a powerful tool in 
the understanding of iron regulation in eukaryotic cells. While significant progress has been 
made, there are still many gaps in our understanding in iron regulation and its role in thiol-
redox control. For instance, we have yet to conclusively identify the sulfur-containing 
substance that is transported out of the mitochondria that is critical for the biogenesis of 
Fe-S proteins in the cytosol and nucleus. Identification of residues that are critical for 
binding of complex proteins responsible for Fe-S cluster transfer and determining factors 
that influence the efficiency of Fe-S transfer is still ongoing in the field of iron regulation. 
These details are vital as they can be used to uncover therapeutic targets in treating diseases 








    
Figure 1.6. Model for regulation of Aft1/2 by Fe-S cluster binding in S. cerevisiae. Fe-
S clusters are synthesized in the mitochondrial matrix by proteins in the Fe-S cluster 
assembly pathway. Once assembled, an unknown sulfur-containing substance is 
transported out of the mitochondria by the Atm1 transporter. GSH is required for the export 
process. Grx3 and Grx4 use GSH to help coordinate Fe-S clusters. This Grx3/4- [2Fe-2S] 
complex is thought to form a heterodimer with Fra2 that then relays a signal to Aft1/2 and 
promotes its dissociation from target DNA. Aft1/2 is therefore deactivated and transported 




Scope of Thesis 
The tripeptide glutathione (GSH) is an essential and multifaceted thiol-containing 
molecule found in all eukaryotic cells. Due to its role in cell signaling, detoxification, 
protein folding, and iron homeostasis, maintenance of GSH pools and redox balance is 
crucial to the overall health of cells. The biosynthesis of GSH occurs exclusively in the 
cytosol. However, distinct GSH pools can be found in subcellular compartments. The 
development of targeted GFP-based probes and intracellular measurements of GSH have 
contributed to our understanding of regulatory processes that affect the subcellular 
environment. Although, there remains many gaps in our understanding of organelle-
specific GSH regulation.  
Mitochondria are the hub for energy production and consequently the primary site 
of ROS generation that can lead to oxidant-induced damage. Evidence points to GSH as  
the primary defense against the harmful effects of increased oxidation in the mitochondria. 
GSH limitation also causes mitochondrial dysfunction, such as respiratory incompetency 
and loss of mitochondrial DNA. Cells depleted of GSH or containing very high GSH 
concentrations have a similar phenotype characterized by redox imbalance, an iron 
starvation-like response, and eventual cell death. In this dissertation we look at factors that 
influence subcellular GSH pools, such as intercompartmental cross-talk and increased 
GSH or GSSG uptake. We also explore how yeast cells cope with extreme changes in 
intracellular GSH.   
Vacuolar storage was found to be important in regulating cytosolic redox 
homeostasis. Since the cytosol and mitochondria possess similar redox regulatory 
mechanisms and GSH concentrations are similar within each compartment, in Chapter 2 
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we discuss the involvement of a vacuolar GSH transporter in regulating mitochondrial 
GSH levels. We show that yeast cells lacking vacuolar storage accumulate more 
mitochondrial GSH when exposed to excess GSH. Additionally, elevated cytosolic and 
mitochondrial GSH was observed in cells grown under oxidative stress caused by excess 
GSSG. Surprisingly, our data suggests that vacuolar storage may act to remove GSH in the 
cytosol prior to its transport to the mitochondria. Therefore, we conclude that vacuole 
storage may be an additional regulatory pathway for the mitochondria to combat redox 
stress.   
 Opt2, an oligopeptide transporter protein and homologue of the S. cerevisiae high 
affinity GSH transporter protein Hgt1, was discovered to be dually localized to the plasma 
membrane and peroxisomes of yeast. Therefore, in Chapter 3 we investigated the potential 
of Hgt1 to be localized to subcellular organelles by specifically testing for its presence on 
the mitochondrial membrane. Secondly, we examined the effect of deletion and 
overexpression of HGT1 on mitochondrial GSH. We found that while Hgt1 does not appear 
to be a mitochondrial GSH transporter, its overexpression in cells treated with extracellular 
GSH increases mitochondrial GSH pools. This is likely due to the high GSH in the cytosol 
diffusing into the mitochondria via other unknown transporters.  Deletion of HGT1, on the 
other hand, had no effect on GSH accumulation in this compartment.  
 GSH depletion in strains has been extensively studied in efforts to understand 
which of the many roles of GSH is essential for viability. These studies revealed that GSH 
is essential for maintaining mitochondrial integrity and maturation of extra-mitochondrial 
Fe-S cluster proteins. Interestingly, high intracellular GSH also impacts iron metabolism 
in addition to protein folding in the ER. Together, these studies shed light on how cells 
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handle low and high levels of GSH. However, we wanted to examine GSH trafficking more 
closely by monitoring subcellular GSH metabolism in a GSH-depleted strain that is 
engineered to accumulate extracellular GSH. In Chapter 4, we developed a model to 
explore the effects of GSH fluctuations by creating a gsh1∆ strain that overexpresses HGT1 
(gsh1∆ + HGT1). Surprisingly, we found that HGT1 overexpression rescues the exogenous 
GSH dependence of a gsh1∆ strain without GSH supplementation. We also tested whether 
a similar phenomenon occurs in minimal media that only contains the necessary amino 
acids for wild type yeast to grow. We find that under these conditions HGT1 is unable to 
sustain growth of gsh1∆ cells. By investigating which amino acids are important for rescue, 
we discovered that cysteine restores growth of gsh1∆ + HGT1 cells. This effect is more 
pronounced under anaerobic conditions, suggesting that rescue is redox-dependent. Our 
results also confirm that HGT1 overexpression in gsh1∆ partially rescues the iron 
starvation response associated with GSH depletion. Therefore, we conclude that HGT1 
overexpression helps cells with low GSH to regulate redox and iron metabolism, although 
the specific mechanism behind the rescue is unclear.  
 Techniques developed or modified for our research needs are described in Chapter 
5. The procedures were adapted from published protocols to obtain the reported results. 
The methods discussed are small-scale mitochondrial isolation, GSH/GSSG plate reader 
assay, GSH uptake into isolated yeast mitochondria, mitochondrial purification, 
construction of deletion plasmids, and monitoring growth of yeast using the Synergy H1 
plate reader.  Collectively, these experiments have allowed us to genetically modify 
intracellular GSH and assess the consequences of these changes in whole cell, cytosolic, 
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EXCHANGE OF GLUTATHIONE BETWEEN VACUOLAR AND MITOCHONDRIAL 




Glutathione (GSH), an abundant low-molecular weight thiol, acts to protect the cell 
from hyper-oxidation and regulate subcellular redox homeostasis. In Saccharomyces 
cerevisiae, the biosynthesis of GSH occurs in the cytosol or may be imported 
extracellularly via a high affinity GSH transporter, Hgt1. The biochemical transport of 
GSH across other membranes has been demonstrated and while advances have been made 
in identifying mechanisms that control GSH homeostasis, our understanding of GSH 
distribution from the cytosol to subcellular compartments remain elusive. The ability of 
cells to regulate GSH pools through subcellular crosstalk has recently been demonstrated. 
Ycf1, a vacuolar GSH S-conjugate transporter of the ATP-binding cassette family, was 
shown to facilitate vacuolar storage of oxidized glutathione (GSSG) not immediately 
reduced by other cytosolic redox pathways. Storage of GSSG in the vacuole was, therefore, 
determined to be an important mechanism for maintaining a reduced cytosolic 
environment. Elucidating the fundamental role of subcellular compartmentalization in 
regulating the cytosolic GSH:GSSG ratio is an important step forward. However, there 
remains many gaps in our understanding of mechanisms that govern intercompartmental 
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exchange of GSH. Given that mitochondrial GSH (mGSH) is derived from the cytosol, we 
hypothesized that vacuolar storage plays a fundamental role in maintaining the redox 
environment in this compartment. Our current studies are designed to explore the role of 
vacuolar storage on mGSH pools under GSH or GSSG overaccumulation conditions. To 
accomplish this, GSH or GSSG was added to the growth media of strains overexpressing 
HGT1. Overaccumulation of GSH and GSSG was measured in wild type (WT) and yeast 
lacking YCF1. We find that disruption of vacuolar storage leads to elevated mitochondrial 
GSH in cells grown with excess GSH. Addition of excess GSSG in a ycf1∆ strain results 
in elevated cytosolic and mitochondrial total GSH. Interestingly, this increase is not due to 
GSSG. Overall, our data suggests that vacuole storage is important for maintaining 
subcellular GSH:GSSG pools under redox stress. 
 
Introduction 
An important mechanism that cells use to rid the intracellular environment of toxins is 
the conjugation of xenobiotics to GSH. This process occurs spontaneously or with the help 
of GSH transferases. Conjugates are then transferred outside the cell or into vacuoles via 
GSH S-conjugate pumps belonging to the ATP-binding cassette family of transporters (1). 
Transporters of the ATP-Binding Cassette (ABC) superfamily are found in all organisms 
and function in the transport of a wide range of harmful compounds across cellular 
membranes (2). In Saccharomyces cerevisiae, the yeast cadmium factor protein (Ycf1) is 
a vacuolar-localized member of the ATP-binding cassette class C (ABCC) transporters. 
YCF1 was originally isolated due to its critical role in cadmium tolerance. The mechanism 
of cadmium (Cd) resistance was determined to be a result of Cd sequestration to the vacuole 
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through the formation of GSH S-conjugates. Surprisingly, reduced GSH itself was also 
identified as a low affinity (Km 15 + 4 mM) substrate of Ycf1. Once inside the vacuole, 
GSH is degraded by the vacuolar membrane-bound proteins, γ-glutamyl transpeptidase and 
dipeptidase. This process of eliminating GSH from the cytosol is analogous to that 
performed on the external surface of the plasma membrane by the human multidrug 
resistance protein MRP1 of which Ycf1 is a close homolog (3–5). Sequestration of GSSG 
from human cells by MRP1 has been detected when cells are under oxidative stress. 
Likewise, uptake of radiolabeled GSSG by Ycf1 has also been directly measured (Km = 
290 + 50 µM) (1). The ability of MRP1 and Ycf1 to transport unconjugated GSSG or GSH 
has placed these transporters as potential regulators of the cellular redox status (6).  
Evidence for the maintenance of intracellular GSH homeostasis has been reported for 
Ycf1 using Saccharomyces cerevisiae. Studies conducted by Paumi et al. found that salt-
induced oxidative stress in ycf1 deletion (ycf1∆) strains increases intracellular reactive 
oxygen species (ROS) formation and reduces free GSH and GSSG. The ratio of 
GSH:GSSG was also decreased as a result of oxidative stress. In addition to changes in 
GSH, Sod1, Sod2, and GSH peroxidase activity were induced in ycf1Δ cells exposed to 
oxidants. Cytoplasmic Sod1 (Cu/ZnSOD), mitochondrial Sod2 (MnSOD), and GSH 
peroxidase have all been shown to protect cells against oxygen toxicity and oxidative 
stress. Therefore, these findings suggest that Ycf1 plays an important role in the regulation 
of cellular redox balance in cytosolic and mitochondrial compartments (2). 
Another indication for the protective role of Ycf1 in redox homeostasis was reported 
by Morgan et al. The authors investigated the role of vacuolar storage in regulating 
cytosolic GSH homeostasis as it relates to subcellular distribution of GSSG. Conventional 
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methods of measuring intracellular GSH and GSSG in combination with monitoring 
dynamic changes of GSH:GSSG redox potentials using targeted green fluorescent protein 
based probes revealed discrepancies in whole cell and subcellular GSH:GSSG. The authors 
report that genetic and chemical elevation of GSSG decreased over time in the cytoplasm 
while whole-cell GSH was unaffected. These results were an indication that GSSG is 
transported into another subcellular compartment. Vacuolar membrane localized ABC-
transporters were evaluated as potential contributors to GSSG storage under oxidative 
stress conditions. Ycf1 was shown to be exclusively responsible for GSSG 
compartmentalization. These findings provided evidence for intercompartmental crosstalk 
(6).  
  Compartmentalization of GSH is assumed to play a key role in maintaining GSH 
redox balance in different subcellular environments. Enzymes responsible for GSH 
biosynthesis are only found in the cytosol. Yet, GSH is required in other organelles such 
as the nucleus, endoplasmic reticulum, and mitochondria. Determining the mechanisms 
that control subcellular transport and distribution of GSH is therefore considered to be 
critical to our understanding of cellular redox homeostasis.  Maintaining mitochondrial 
GSH is especially important since this organelle is the site of ROS production and changes 
in mitochondrial GSH levels is associated with pathologies such as aging, diabetes, 
neurological disorders, liver diseases, and pulmonary diseases (7).  
 In the current study, we set out to determine the underlying mechanisms that govern 
intercompartmental exchange of GSH between the cytosol and the mitochondria. 
Mitochondria contain a distinct pool of GSH with concentrations similar to the cytosol (10-
14 mM). Both compartments also rely on GSSG reductase (GLR) to maintain the high 
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GSH:GSSG ratio (8). Therefore it is plausible that under redox stress, vacuolar storage is 
important for regulating mitochondrial GSH:GSSG homeostasis. To test this, our lab has 
employed the HGT1 overexpression plasmid, which allows GSH and GSSG to 
overaccumulate in cells when GSH or GSSG is added to the growth media (9). By 
increasing intracellular GSH and GSSG, a form of redox stress, we are then able to monitor 
changes in subcellular GSH:GSSG pools. Using targeted GFP-based redox sensors, our 
previous studies showed that adding GSH and GSSG to the media of HGT1 strains lacking 
vacuolar storage protein Ycf1 (ycf1∆) alters the mitochondrial GSH:GSSG redox state 
(10). To correlate these redox changes with direct measurement of subcellular GSH and 
GSSG levels and elucidate the role of vacuolar storage on mitochondrial GSH, we 
measured cytosolic and mitochondrial GSH levels in WT and ycf1∆ strains expressing the 
HGT1 plasmid. Our results suggest that reductive (excess GSH) and oxidative (excess 
GSSG) stress cause increased mitochondrial GSH accumulation when vacuolar storage is 
lacking, whereas only oxidative stress results in elevated cytosolic GSH in ycf1∆ + HGT1 
strains. The observed differences in WT and ycf1∆ GSH accumulation appear to be in the 
form of reduced GSH.  
 
Experimental Procedures  
Yeast Strains, Plasmids, Media, and Growth Conditions- The Saccharomyces 
cerevisiae strains used in this study were derivatives of WT BY4742 (MAT his3Δ1 leu2Δ0 
lys2Δ0 ura3Δ0). The BY4742 ycf1::kanMX4 was a kind gift from Dr. Tobias Dick (6). The 
CEN pTEF-416 vector and pTEF-416-HGT1 overexpression plasmids carrying URA3 
selection were inserted into WT and ycf1∆ strains (9, 11). Yeast transformations were 
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performed using standard lithium acetate transformation protocols (12). Cells were grown 
in synthetic complete (SC) selection media (0.671% yeast nitrogen base without amino 
acids and ammonium sulfate (US Biological), 2% glucose) and supplemented with 
appropriate amino acids. All assays were done using cells grown to mid-log phase.  
Small Scale Mitochondrial Isolation- Yeast cells were grown aerobically to mid-
log phase in SC selection medium with 2% glucose. Cytosolic and mitochondrial fractions 
were obtained as previously described by converting cells to spheroplasts followed by 
gentle lysis using a loose fitting Dounce homogenizer and differential centrifugation (13). 
Incubation with reductant (dithiothreitol) was omitted from fractionation steps to avoid 
alteration of the GSH:GSSG redox state, and protease inhibitors were omitted since protein 
integrity was not a concern for the subsequent assays. Protein concentrations were 
measured using the Bradford method with bovine serum albumin as a calibration standard. 
 GSH/GSSG Assay-Total GSH (GSH and GSSG) was measured in cytosolic and 
mitochondrial extracts using the 5,5-dithiobis(2-nitrobenzoic acid) (DTNB)-GSSG 
reductase cycling assay as previously described (14, 15). Subcellular fractions were 
prepared as described above (13). Samples were incubated with 1% 5-sulfosalicylic acid 
(SSA) on ice for 30 minutes and fractions were spun at 13000 x g at 4 °C. The supernatant 
containing total GSH was transferred to sterile microcentrifuge tubes. GSSG samples were 
prepared by alkylating total GSH samples with 2-vinylpyridine. DTNB reduction was 
monitored at 412 nm. Absorption measurements were taken every 15 seconds for 
approximately 2 minutes (15). Standard concentrations of GSH and GSSG are obtained by 
using known concentrations of GSH or GSSG solubilized in 1% SSA. The reported 
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GSH/GSSG measurements are the rate of increasing absorbance directly proportional to 
GSH/GSSG concentration over a range of 2 minutes. 
 
Results 
 Disruption in vacuolar storage causes increased mitochondrial accumulation of 
GSH in HGT1 expressing strains- To examine how overaccumulation of GSH impacts 
GSH pools in subcellular compartments, we transformed an HGT1 overexpression plasmid 
into WT yeast. After addition of 100 µM GSH to the growth medium, total GSH (GSH + 
GSSG) measurements of subcellular fractions reveal that GSH accumulation occurs in both 
the cytosol and mitochondria of WT + HGT1 cells (Fig. 2.1A,B). These data are in 
agreement with previous studies showing that whole cell GSH significantly increases in 
WT + HGT1 strains when GSH is added to the growth media (9). Furthermore, these results 
demonstrate that the excess GSH is clearly imported into mitochondria.  
 We next wanted to evaluate how vacuolar storage affects GSH distribution from 
the cytosol to the mitochondria. To test this, we used a ycf1∆ deletion strain containing 
HGT1 overexpression or empty vector control plasmids. Mitochondria were separated 
from the cytosol and fractions were evaluated for total GSH + GSSG content. WT + HGT1 
and ycf1Δ + HGT1 cells showed no difference in cytosolic GSH accumulation (Fig. 2.1A). 
However, ycf1Δ + HGT1 accumulated 1.6X more total mitochondrial GSH than the WT 
control (Fig. 2.1B). These data imply that with GSH overaccumulation, mitochondria 
partially rely on vacuolar storage of GSH to regulate GSH pools. 
GSH overaccumulation increases GSSG steady-state levels in the cytosol and 







Figure 2.1 Disruption in vacuolar storage causes increased mitochondrial 
accumulation of GSH in HGT1 expressing strains. Cells were grown overnight at 30 °C 
to an OD600 of approximately 1 in SC selection media. Select cells were treated with 100 
µM GSH for 30 minutes. Cytosolic and mitochondrial fractions were collected and 
acidified with 1% SSA. The DTNB spectrophotometric assay was used to measure (A) 
cytosolic and (B) mitochondrial steady-state total GSH (GSH + GSSG) concentrations in 
WT BY4742 and ycf1∆ strains transformed with vector control and HGT1 overexpression 
plasmids. The reported data are from 3 independent experiments with the error bars 
representing the standard deviation.
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of total GSH measured in subcellular compartments, cellular GSH:GSSG extracts were 
alkylated with 2-vinylpridine so that only GSSG could be assessed. Our studies measuring 
cytosolic GSH showed that WT + HGT1 and ycf1Δ + HGT1 strains accumulated 
approximately the same amount of total GSH (GSH + GSSG) (see Fig. 2.1A). However, 
when GSSG was measured alone, we show that WT + HGT1 cells have 1.7X more GSSG 
than ycf1Δ + HGT1 (Fig. 2.2A). These data suggest that WT and ycf1∆ regulate cytosolic 
GSH:GSSG differently when subject to GSH overaccumulation. However, the mechanism 
of regulation is yet to be determined. Next, we looked at GSSG levels in mitochondrial 
fractions of WT and ycf1∆ cells expressing HGT1 and vector plasmids. Since mitochondria 
of ycf1Δ + HGT1 cells appear to accumulate more total GSH from the media than WT + 
HGT1, we wanted to determine if GSH pools in this compartment are reduced or oxidized. 
Previous studies using targeted GFP-based probes have found the mitochondrial matrix to 
be very reducing (16). Here, we see that the increase of total GSH in ycf1Δ+ HGT1 appears 
to be mostly reduced GSH (Fig. 2.2B). Therefore, we conclude that vacuolar storage may 
be important for storing excess reduced GSH in addition to GSSG. However, these 
experiments should be repeated to confirm that these differences between WT and ycf1∆ 
strains are reproducible and statistically significant.  
 Disruption in vacuolar storage causes accumulation of cytosolic and mitochondrial 
total GSH in high GSSG stress - Previous studies showing the involvement of Ycf1 in 
regulating cellular GSH homeostasis were done by increasing GSSG intracellularly and 
exposing cells to other oxidants. Data evaluating GSH levels and redox changes of the 








Figure 2.2 GSH overaccumulation increases GSSG steady-state levels in the cytosol 
and mitochondria of WT and ycf1∆ strains overexpressing HGT1. WT BY4742 and 
ycf1∆ strains expressing vector control and HGT1 overexpression plasmids were grown 
overnight at 30 °C to an OD600 of approximately 1.0 in SC media. Select cells were treated 
with 100 µM GSH for 30 minutes. DTNB spectrophotometric analysis was used to measure 
steady state GSSG concentrations of (A) cytosolic and (B) mitochondrial fractions. The 







homeostasis (2, 6). To further explore the role of GSH sequestration to the vacuole in 
regulating GSH at the subcellular level, we directly measured GSH and GSSG levels 
following GSSG overaccumulation from the extracellular environment of WT + HGT1 and 
ycf1Δ + HGT1 strains. Total GSH levels spike in both WT and ycf1Δ strains expressing 
HGT1 with addition of GSSG to the growth medium. However, ycf1Δ + HGT1 
accumulated 1.7X more cytosolic GSH than WT + HGT1 (Fig. 2.3A). These results 
corroborate reports by Morgan et al. showing that a ycf1Δ strain genetically modified to 
accumulate GSSG have larger GSSG content in whole cell lysates compared to the control 
(6). We also checked the effect of vacuolar storage on the mitochondria of strains with 
enhanced import of extracellular GSSG. Surprisingly, mitochondria of ycf1Δ + HGT1 cells 
accumulated 1.3X more GSH than the control (Fig. 2.3B). Taken together, these data show 
that Hgt1 imports large amounts of GSSG from the extracellular environment which causes 
increased total GSH that is distributed to the mitochondria. Additionally, Ycf1 is not only 
important for maintaining cytosolic GSH but may also be key in regulating mitochondrial 
GSH. 
 GSSG overaccumulation in HGT1 strains increases GSSG steady-state levels in the 
cytosol and mitochondria of WT and ycf1∆ strains- Under GSSG overaccumulation 
conditions, ycf1Δ + HGT1 was shown to have a larger accumulation of total GSH than the 
WT control (see Fig. 2.3A,B). Therefore, we investigated the amounts of GSSG in the 
cytosol and mitochondria of WT + HGT1 and ycf1Δ + HGT1 cells. We report that WT + 
HGT1 strains acquire 2.4X more cytosolic GSSG than ycf1Δ + HGT1 strains (Fig. 2.4A). 
Interestingly, mitochondrial GSSG increases 3X more in WT cells than ycf1∆ strains that 







Figure 2.3 Disruption in vacuolar storage causes accumulation of cytosolic and 
mitochondrial total GSH in high GSSG stress. Yeast strains were grown overnight to 
mid-log phase at 30 °C in SC selection media. Cells were split and select cells were treated 
with 50 µM GSSG for 30 minutes. Acidification of cytosolic and mitochondrial fractions 
using 1% SSA was done prior to measuring (A) cytosolic and (B) mitochondrial steady 
state total GSH (GSH + GSSG) concentrations in WT BY4742 and ycf1∆ strains 
transformed with vector control and HGT1 overexpression plasmids using the DTNB 
spectrophotometric assay. The reported data are from 3 independent experiments with the 







Figure 2.4 GSSG overaccumulation in HGT1 strains increases GSSG steady-state 
levels in the cytosol and mitochondria of WT and ycf1∆ strains.  WT BY4742 and ycf1∆ 
strains expressing vector and HGT1 overexpression plasmids were grown overnight at 30 
°C to mid-log phase in SC media. Select cells were treated with 50 µM GSSG for 30 
minutes and the steady state GSSG concentrations of (A) cytosolic and (B) mitochondrial 
fractions were measured using the DTNB colorimetric assay. The reported data are from 3 
independent experiments with the error bars representing the standard deviation. ND, not 





strains is reduced, it seems that GSSG reductase (GLR) and possibly the TRX and GRX 
redox systems are likely responsible for the rapid reduction of imported GSSG. These 
redox regulatory pathways are localized to the cytosol and mitochondria and act to maintain 
GSH:GSSG. Previous studies found that thiol-reductase systems along with vacuolar 
storage works together to alleviate oxidative stress from the cytosol caused by elevated 
GSSG (6). We provide evidence that expression of Ycf1 effects mitochondrial GSH pools 
as well as cytosolic pools. However, our studies suggest that reduced GSH may also be 
stored in the vacuole to maintain the redox environment of subcellular organelles. Further 
genetic and molecular testing is needed to confirm the ways in which vacuolar storage 
regulates mitochondrial GSH.  
 
Discussion 
 We investigated the distribution of GSH and GSSG accumulated from the 
extracellular environment between the cytosol and the mitochondria of strains 
overexpressing HGT1. This study revealed that intracellular overaccumulation of GSH is 
distributed between subcellular organelles. Specifically, imported GSH and GSSG to the 
cytosol of HGT1 strains results in elevated mitochondrial GSH and GSSG. Our ability to 
selectively look at increased GSH pools in the mitochondria allowed us to investigate the 
role of vacuolar storage in maintaining mitochondrial GSH levels. Ycf1 is the only 
vacuolar-localized ABC transporter in Saccharomyces cerevisiae identified as a regulator 
of cellular GSH (6). Therefore, a genetically modified strain where YCF1 was deleted and 
transformed with an HGT1 overexpression plasmid was used to determine the impact of 
vacuolar storage on mitochondrial GSH and GSSG.  
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 Steady-state levels of accumulated GSH were measured in cytosolic and 
mitochondrial fractions of ycf1∆ + HGT1 strains when cells were exposed to GSH. As 
expected, cytosolic and mitochondrial total GSH + GSSG was elevated in this strain. 
Interestingly, mitochondrial GSH + GSSG of ycf1∆ + HGT1 showed increased total GSH 
accumulation compared to the WT strain. These data suggest that the loss of GSH export 
to the vacuole effects the amount of total GSH (GSH + GSSG) transported to the 
mitochondria. On the contrary, no difference in the cytosolic total GSH was measured.  
 Vacuolar storage was not only found to effect GSH levels but also the 
GSH:GSSG ratio (2, 6). Therefore, we measured GSSG levels of strains treated with 
reduced GSH. GSSG measurements showed that while there was no difference in total 
cytosolic GSH, GSSG levels in the ycf1∆ + HGT1 strain were found to be lower than the 
WT strain. Likewise, the mitochondrial GSH accumulated was primarily in the reduced 
form in ycf1∆ + HGT1. Observing a smaller mitochondrial GSSG pool was interesting 
given that total GSH was elevated in ycf1∆ + HGT1 compared to WT + HGT1. Thus, we 
conclude that ycf1∆ strains regulate both the cytosolic and mitochondrial redox state 
differently than WT and reductive systems such as GLR, the thioredoxin (TRX) and 
glutaredoxin (GRX) pathways may be responsible for these variations.  
 The human homologue of Ycf1, MRP1, has been demonstrated to exhibit GSSG 
transport actitivy (17, 18). Ycf1 has also been shown to regulate intracellular GSH when 
exposed to oxidants (2, 6). Therefore, in this study we directly measured changes in 
subcellular GSH when HGT1 cells are grown in the presence of GSSG. We find that the 
import of GSSG causes cytosolic and mitochondrial total GSH to spike. HGT1 strains 
where ycf1 was deleted have an even greater accumulation of total GSH in both the cytosol 
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and mitochondria. While Ycf1 has already been shown to affect the cytosol GSH pool of 
strains with elevated GSSG, we present for the first time evidence that the vacuole may 
play a role in mitochondrial redox homeostasis. GSSG was also measured in WT + HGT1 
and ycf1∆ + HGT1 cells exposed to GSSG. To our surprise, GSSG was lower in the cytosol 
and mitochondria of ycf1∆ + HGT1. Therefore, Ycf1 may be important for storing 
imported GSSG that had been reduced by cytosolic thiol reductases pathways prior to 
entering the vacuole. Taken together our studies suggest that vacuolar storage is involved 
in maintaining mitochondrial GSH and GSSG pools when cells are exposed to high GSH 
and GSSG levels. The cytosol, however, depends on vacuolar storage under the threat of 
increased oxidant exposure. These observations are important for our understanding of 
intercompartmental crosstalk. However, future studies are welcomed so that the 
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Several mitochondrial functions rely on thiol-disulfide homeostasis and are thus 
influenced by glutathione (GSH) metabolism. These functions include maintaining the 
membrane structure and integrity, the activity of various sulfhydryl-dependent enzymes, 
and ion homeostasis. Despite GSH being exclusively made in the cytosol, mitochondria 
contain distinct GSH pools. This GSH is thought to originate from the transport of GSH 
from the cytosol across the mitochondrial inner membrane. However, the specific 
mitochondrial transporter that imports GSH into mitochondria has not been identified in S. 
cerevisiae. Here we investigated the role of Hgt1/Opt1, the plasma membrane high affinity 
GSH transporter, in mitochondrial GSH transport. A previous study found that Opt2, a 
close homolog of Hgt1/Opt1, is dually localized to the plasma membrane and peroxisomes 
of yeast. To determine if Hgt1 also exhibits dual localization to the plasma and 
mitochondrial membranes in a similar manner, we overexpressed Hgt1 with a 
hemagglutinin tag. Subcellular fractionation and western blot analysis suggested that Hgt1 
is indeed localized to crude mitochondrial fractions. To elucidate if Hgt1 is specifically 
localized to the mitochondrial membrane, we further purified crude mitochondrial fractions 
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in hopes of removing plasma membrane contamination. While purified mitochondrial 
fractions were devoid of endoplasmic reticulum, vacuolar, and cytosolic fractions; we were 
unable to separate mitochondria from plasma membrane. Num1, the core component of the 
mitochondria-endoplasmic reticulum [ER]-cortex anchor (MECA) tethers mitochondria to 
the plasma membrane. To determine if plasma membrane contamination was due to Num1 
expression, we used a NUM1 deletion (num1∆) strain overexpressing HA-tagged Hgt1. 
However, plasma membrane contamination was not removed in these strains. We further 
analyzed Hgt1’s role in regulating mitochondrial GSH pools using genetic modifications 
of genes that influence GSH pools. Here we report that an HGT1 deletion (hgt1∆) strain 
does not affect mitochondrial GSH levels. Similarly, incubation of isolated mitochondria 
in GSH1 deletion (gsh1∆) strains overexpressing HGT1 does not result in increased GSH 
uptake. Taken together, these studies show that cytosolic uptake of GSH by Hgt1 increases 
mitochondrial GSH. However, Hgt1 does not directly affect mitochondrial GSH pools and 
is unlikely a mitochondrial GSH transporter.  
 
Introduction 
Redox chemistry is thought to play a pivotal role in understanding cellular processes 
such as oxidant-dependent signaling and cell fate decisions (1). Therefore, characterizing 
the redox environment within cells is vital to understanding diseases related to redox 
changes. Previously, research designed to understand cellular redox homeostasis was 
performed using whole cell measurements. These studies revealed important information 
regarding redox homeostasis; however, the differences in redox regulation mechanisms 
between subcellular compartments was not elucidated until recently (2). More recent 
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studies show that while GSH is exclusively made in the cytosol, it is transported across 
various membranes and is required for the function of other organelles (3).  Saccharomyces 
cerevisiae has been extensively used to study GSH transport. In fact, the first high affinity 
GSH transporter, Hgt1, was discovered in this organism as well as other transporters 
localized to subcellular compartments (4, 5).    
 Redox balance is particularly important in the mitochondria since this organelle 
contains several proteins involved in redox signaling, apoptosis, and bioenergetics. 
Mitochondria are also subject to DNA mutations and oxidative damage caused by reactive 
oxygen species (ROS) produced during oxidative metabolism. To prevent hyper-oxidation, 
mitochondria rely on an array of antioxidants and detoxifying enzymes, with the redox 
active tripeptide GSH being the main line of defense. The importance of mitochondrial 
GSH is highlighted not only by its abundance but its ability to detoxify hydrogen peroxide, 
lipid hydroperoxides, and xenobiotics by serving as a cofactor to GSH peroxidases or 
glutathione-S-transferases (6). Further evidence supporting the critical nature of GSH in 
maintaining mitochondrial redox homeostasis are reports in which chemically depleted 
mitochondrial GSH, as opposed to cytosolic GSH, led to cellular injury in liver and kidney 
cells (7, 8).  
Many studies using isolated mitochondria along with targeted green fluorescent protein 
(GFP) based probes have investigated mitochondrial GSH redox potentials and other 
subcellular pools. While these methods provide insight into the redox state of GSH in this 
organelle, the molecular mechanisms that control mitochondrial redox balance remain 
elusive. One key factor that eludes our understanding is the mechanism of GSH transport 
into this compartment. GSH is thought to freely diffuse through the outer membrane of the 
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mitochondria via porin channels (9). However, transport of GSH across the mitochondrial 
inner membrane is energetically unfavorable because it is negatively charged at 
physiological pH and the mitochondrial matrix is negatively charged. Thus, it is believed 
that a GSH transporter is required for import. Due to the overall negative charge of GSH, 
it was proposed that anionic carriers of the mitochondrial inner membrane could import 
GSH into the matrix (10). Research conducted by Chen et. al. using rat kidney and liver 
tissue identified two anionic carriers, dicarboxylate and 2-oxoglutarate carriers, as 
responsible for GSH uptake into the mitochondrial matrix (10, 11).  Conversely, a more 
recent report in which human and yeast dicarboxylate and 2-oxoglutarate carriers were 
overexpressed in fused membrane vesicles of Lactococcus lactis, concluded that these 
carriers do not transport GSH (12).  Therefore, an unambiguous mitochondrial GSH 
importer has yet to be identified.  
Elbaz-Alon et al. discovered via colocalization studies using fluorescently tagged 
proteins that Opt2 exhibits dual localization to the plasma membrane and peroxisomes of 
yeast. Additionally, Opt2 was found to not only affect cytosolic and peroxisomal 
GSH:GSSG but mitochondrial GSH:GSSG homeostasis as well (13). Therefore, our lab 
set out to determine whether Hgt1 exhibits dual localization to the plasma and 
mitochondrial membranes. We also wanted to determine how Hgt1 affects subcellular GSH 
pools. A hemagglutinin (HA)-tagged Hgt1 overexpression plasmid coupled with 
mitochondrial isolation and purification was used to investigate the localization of Hgt1 to 
the mitochondrial fraction. Unfortunately, with this method Hgt1 localization to the 
mitochondria could not be determined with certainty.  
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Strains overexpressing HGT1 have been shown to uptake extracellular GSH from the 
media into the cell, resulting in a 7-10 fold increase in GSH and GSSG (14). Therefore, we 
wanted to determine if Hgt1 had any effect on mitochondrial GSH pools. Our results 
showed that while it could not be determined if Hgt1 was localized to the mitochondrial 
membrane, redox stress caused by GSH uptake from the extracellular environment by Hgt1 
does affect mitochondrial GSH pools.  
 
Experimental Procedures 
Yeast Strains, Plasmids, Media, and Growth Conditions- The S. cerevisiae strains 
used in this study were derived from the wild type (WT) strain BY4741 (MATa his3Δ1 
leu2Δ0 met15Δ0 ura3Δ0). Deletion strains num1::kanMX4 and hgt1::kanMX4 were 
purchased from Open Biosystems. Deletion of HGT1 was confirmed by PCR colony 
screening using primers recommended by the Saccharomyces Genome Deletion Project 
(Table 3.1, primers used for PCR screening) (15). The gsh1∆ strain was made by deleting 
the GSH1 gene using pGSH1KO (see plasmid construction for more information).  Yeast 
transformations were performed using standard lithium acetate transformation protocols 
(16). Yeast strains were cultured at 30 °C in synthetic complete (SC) media (US Biological) 
supplemented with either 2% glucose or 2% galactose as the carbon source with the 
appropriate amino acids.   
Plasmid Construction- The GSH1 deletion plasmid (pGSH1KO) was created by 
cloning flanking regions of the GSH1 gene. Briefly, upstream and downstream regions of 
GSH1 were amplified using primers engineered with BamHI, SalI, and EcoRI cut sites 






Table 3.1 Primers used to check for HGT1 deletion (15). 
Primer Name Primer Sequence 
Hgt1_ A_SCRN GTCACACAAAATCCAGGACAATAG       
Hgt1_ B_SCRN TCAAAATGTACATAGCGTATGCAGT 
Hgt1_ C_SCRN GCATAATATCGATGGCTTATGTACC   












Table 3.2 Primers used to make pGSH1KO (restriction enzyme sites are underlined in 
primer sequence). 
 
Primer Name Primer Sequence Restriction 
Enzyme 
GSH1KO Primer A GATTATATTGAATTCTTGTGCTGGAG EcoRI 
GSH1KO Primer B GATTCCACGGATCCTTAATG BamHI 
GSH1KO Primer C GATTTGCTGTCGACGTGTGATAG SalI 




integrating vector (pRS403) with a HIS3 selection marker at the BamHI and SalI sites. The 
yeast integrating plasmid was linearized with EcoRI and inserted into the genome of yeast 
strains via homologous recombination. The p416-TEF-HGT1 plasmid (CEN, URA3) which 
allows HGT1 to be constitutively expressed via the TEF1 promoter was a kind gift from 
Anand Kumar Bachhawat (5, 14, 17).  
Small Scale Mitochondrial Isolation- To separate the cytosolic and mitochondrial 
fractions, yeast strains were plated on 2% glucose SC media for 2-3 days. Cells were then  
cultured in SC with 2% galactose at 30 °C overnight until reaching O.D. ~ 1.0. Cells were 
washed with deionized water followed by SOR buffer (1.2 M sorbitol, 20 mM Hepes, pH 
7.5). Pelleted cells were resuspended in SOR buffer and lysed with zymolyase for 30 min 
to 1 hour.  To prevent protein degradation, spheroplasts were placed on ice and resuspended 
in ice-cold SM buffer (250 mM sucrose, 10 mM MOPS, pH 7.2) containing protease 
inhibitors. Organelle release was obtained via Dounce homogenization which disrupts the 
plasma membrane. The homogenate containing cytosol and crude mitochondria was 
separated from unbroken cells and nuclei by centrifugation at 3000 rpm for 5 min at 4 °C. 
After saving some of this low-speed centrifugation supernatant, the remainder was 
centrifuged at 12000 rpm for 10 min at 4 °C, separating the mitochondria from the post-
mitochondrial supernatant (PMS) (18). The crude mitochondrial pellet was carefully 
washed with SM buffer and diluted to desired volume.  
GSH/GSSG Assays- Spectrophotometric analysis of GSH concentration was 
determined by creating whole cell lysates of 2  107 cells for strains with normal GSH 
levels or 2  109 cells for GSH-depleted gsh1∆ strains. Cell lysates were resuspended in 
1% SSA (5-sulfosalicylic acid) and broken in a bead beater with acid-washed glass beads. 
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The broken cells were centrifugation at 13000 x g for 5 min to pellet out the precipitated 
protein (19). GSH concentration in the supernatant was determined by mixing 20 µL of 
acidified lysate with 180 µL reaction mix (0.1 mM Na-phosphate, pH 7.5, 1 mM EDTA, 2 
mM DTNB (5,5'-dithiobis(2-nitrobenzoic acid)), 1 mM NADPH) and 3 U/mL GSSG 
reductase. The reduction of DTNB to TNB (2-nitro-5-thiobenzoic acid) via GSH was 
monitored at 412 nm. Absorption measurements were taken every 15 seconds for 
approximately 2 minutes (20). Standard concentrations of GSH are obtained by using 
known concentrations of GSH solubilized in 1% SSA. The rate of increasing absorbance 
is directly proportional to GSH concentration over a range of 2 minutes.  
Large Scale Mitochondrial Isolation and Purification- Yeast cells were cultured in 
SC with 2% galactose media (to promote mitochondrial biogenesis) at 30 °C overnight to 
O.D. ~1.0. The next morning, cells were diluted into large volumes and grown to mid-log 
phase. Mitochondrial isolation and purification was conducted according to a previously 
published method (21). In brief, cells were washed with water and incubated with DTT 
buffer (100 mM Tris-H2SO4, pH 9.4, 10 mM DTT (dithiothreitol)) at 30°C for 20 min. 
Pelleted cells were washed with zymolyase buffer (1.2 M sorbitol, 20 mM potassium 
phosphate, pH 7.4) and lysed with 3 mg of zymolyase per g cells for 30-45 minutes. 
Spheroplasts were resuspended in ice-cold homogenization buffer (0.6 M sorbitol, 10 mM 
Tris-HCl, pH 7.4, 1 mM EDTA, 1 mM PMSF, 0.2% BSA) containing protease inhibitors. 
Organelles were released via Dounce homogenization. Cytosolic and mitochondrial 
fractions were separated from unbroken cells and nuclei by centrifugation at 4000 g for 5 
min at 4 °C. Crude mitochondria were isolated from the cytosol by centrifugation at 12000 
g for 10 min at 4 °C. The mitochondrial pellet was washed with SEM buffer (250 mM 
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sucrose, 1 mM EDTA, 10 mM MOPS-KOH, pH 7.2) and diluted to desired volume (22). 
Purification of crude mitochondria was done over a sucrose step gradient using 15%, 23%, 
32%, and 60% sucrose prepared in EM buffer (1 mM EDTA, 10 mM MOPS-KOH, pH 
7.2). Mitochondria were carefully loaded on top of the sucrose gradient and centrifuged at 
134000 g (33000 rpm) for 1 hour at 4 °C using a Beckman SW41 Ti Swinging-bucket 
Rotor. Recovered purified mitochondria from the 60%/32% interface were washed with 
SEM buffer and diluted to desired volume (21).  
SDS-PAGE and Immunoblotting Techniques- SDS-PAGE analysis was used to 
separate protein fractions via electrophoresis on 12% Tris-Glycine gels (Invitrogen). 
Samples were prepared by treatment with 1X SDS (sodium dodecyl sulfate) loading buffer 
containing 0.6 M DTT followed by heating at 95 °C prior to sample loading. The separated 
protein was then transferred to a nitrocellulose membrane and blocked at room temperature 
for 1 hour in 5% TBST milk blocking buffer (1X TBS, 0.1% Tween-20 with 5% w/v nonfat 
dry milk). Immunoblotting was performed using HA antibodies (1:1000, rabbit IgG, Santa 
Cruz Biotechnology), Pgk1 antibodies (1:10,000, mouse IgG monoclonal, Invitrogen), 
Porin (1:10,000 mouse IgG monoclonal, Invitrogen), Cpy1 (1:10,000 mouse IgG 
monoclonal, Invitrogen), Dpm1 (1:10,000 mouse IgG monoclonal, Invitrogen), and Pma1 
(1:10,000 mouse IgG monoclonal, Invitrogen) in blocking buffer.  
GSH Uptake into Isolated Mitochondria- GSH uptake into purified mitochondria 
was performed according to a previously published protocol. Incubation steps with DTT 
and protease inhibitors or PMSF were omitted (18). Freshly prepared mitochondria were 
purified according to the small mitochondrial isolation protocol listed above. Crude 
mitochondria were treated with 15 mM GSH resuspended in SM buffer and untreated cells 
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were used as a control. A 27% sucrose cushion prepared in EM buffer was layered under 
the mitochondria using a syringe. Samples were placed in the 30 °C incubator for 30 
minutes to allow uptake of GSH. Afterwards, mitochondria were centrifuged through the 
sucrose cushion at 14000 X g for 10 minutes at 4 °C. Pelleted mitochondria were washed 
with SM buffer and centrifuged (23). The resulting mitochondrial pellet was acidified with 
1% SSA on ice for 30 minutes. Lysates were centrifuged at 13000 x g and the supernatant 
was transferred to new tube. Total GSH was measured in isolated mitochondria using the 
GSH/GSSG DTNB cycling assay as previously described (20).  
 
Results 
Incubation of 100 µM GSH in yeast overexpressing HGT1 increases cytosolic and 
mitochondrial GSH- In our previous studies, we observed a spike in mitochondrial GSH in 
yeast strains overexpressing HGT1. Therefore, we set out to determine if this increase is a 
result of excess cytosolic GSH being shuttled into the mitochondria or if Hgt1 is localized 
to the mitochondrial membrane. Using a spectrophotometric enzyme cycling assay, we 
measured the steady state concentrations of GSH in cytosolic and mitochondrial fractions 
of cells treated with 100 µM GSH using untreated cells as a control. Again, we see that 
intracellular GSH is elevated in both the cytosol and mitochondria. Overexpression of the 
Hgt1 transporter alone, however, does not affect cytosolic or mitochondrial GSH levels in 
the absence of added GSH to the media, as seen in untreated cells (Fig. 3.1). These results 
agree with research done by Kumar et. al. showing that intracellular GSH spikes within an 









Figure 3.1 Incubation of 100 µM GSH in yeast overexpressing HGT1 increases 
cytosolic and mitochondrial GSH. HGT1 overexpression plasmid or the vector control 
was transformed into WT strain BY4741. Intracellular GSH was determined for cells 
incubated with extracellular GSH by growing cells overnight to exponential phase and 
adding 100 µM GSH to media to select cells for 20 min. Cytosolic and mitochondrial 
fractions were isolated and the total GSH in each extract was measured using the DTNB 






together, these results demonstrate that HGT1 overexpression specifically impacts both 
cytosolic and mitochondrial GSH levels.  
Deletion of HGT1 impairs uptake of cytosolic GSH but has no effect on 
mitochondrial GSH- To further understand if Hgt1 has any effect on mitochondrial GSH 
pools, we used a genetically modified strain where HGT1 was deleted. Subsequently, GSH 
was measured in cytosolic and mitochondrial fractions collected from cells treated with 
100 µM GSH for 30 minutes as well as from the untreated cells (Fig. 3.2). As expected, 
HGT1 deletion lead to lower cytosolic uptake of GSH-treated cells. These data are in 
agreement with results reported by Bourbouloux et al. that found deleting HGT1 
significantly reduced the ability of yeast cells to import radioactive GSH (5). However, we 
did not find that mitochondrial GSH uptake was affected in hgt1∆ strains compared to WT 
strains. These results indicate that Hgt1 is not the primary mitochondrial GSH transporter 
or may be only partially responsible for GSH uptake if there are multiple GSH entry routes 
into mitochondria. 
Hgt1-HA is localized to crude mitochondrial fractions- To explore the possibility 
that Hgt1 is intracellularly localized, we employed an HGT1 overexpression plasmid 
containing a C-terminal HA tag that was gifted to us by Anand Kumar Bachhawat (17). 
Yeast cells were fractionated and western blot analysis was performed to determine the 
localization of Hgt1-HA (Fig. 3.3). As expected, Hgt1-HA was found in whole cell lysates 
that include the plasma membrane. The cytosolic fraction was almost completely devoid 
of Hgt1-HA. Surprisingly, crude mitochondrial fractions contained the Hgt1-HA protein. 
The results indicate that Hgt1-HA co-localizes with mitochondrial fractions and could 








Figure 3.2 Deletion of HGT1 impairs uptake of cytosolic GSH but has no effect on 
mitochondrial GSH. WT BY4741 and hgt1∆ yeast were grown overnight to mid-log 
phase in SC media. Subsequently, 100 µM GSH was added to the growth media and cells 
were harvested after 20 minutes.  Cytosolic and mitochondrial fractions were isolated and 
the total GSH in each extract was measured using the DTNB enzyme cycling assay. Error 










Figure 3.3 Hgt1-HA is localized to crude mitochondrial fractions. Cells transformed 
with empty vector (WT) or HGT1-HA plasmid were lysed and fractionated into cytosolic 
and crude mitochondrial (mito) fractions. Whole cell and total lysates (containing the 
cytosolic and crude mitochondrial fraction) were saved prior to fractionation and used as 
controls. 75 µg of protein was loaded for whole cell, total, and cytosolic compartments. 15 
µg of mitochondrial protein was added to the gel. All fractions were analyzed using SDS-





subcellular compartments such as ER and vacuole, as well as plasma membrane,(22) the 
exact localization of the Hgt1-HA protein could not be determined using this method. 
Hgt1-HA is localized to purified mitochondrial fractions-To determine if Hgt1-HA 
is truly localized to the mitochondria when overexpressed, we proceeded to purify crude 
mitochondria using density gradient ultracentrifugation. Western blot analysis was 
performed on whole cell, cytosolic, crude mitochondria and purified mitochondrial 
fractions (Fig 3.4). Using this method, we successfully separated the mitochondria from 
vacuolar and most ER contamination. These results suggest Hgt1-HA in the crude 
mitochondria fraction was not localized to these compartments. Unfortunately, we were 
not able to successfully separate the plasma membrane from the purified mitochondrial 
sample. Therefore, we cannot conclusively state that Hgt1 is dually localized to the 
mitochondrial and plasma membranes.  
Plasma membrane contamination of purified mitochondria is not due to Num1 
mito-ER tethering- During cell division, mitochondria are inherited from the mother to the 
daughter cells. This process involves tethering of the mitochondria to the plasma membrane 
(24). The proper positioning of mitochondria in budding yeast requires the mitochondria–
ER cortex anchor (MECA), of which Num1 is the principal component. The C-terminal 
pleckstrin homology domain of Num1 interacts with the plasma membrane while the N-
terminal coiled-coil domain of Num1 interacts with mitochondria (25). This interaction 
facilitates cluster formation of Num1 dimers, which is essential for tethering of the plasma 
membrane to the mitochondria (26). Here we investigated whether Num1 tethering was 
responsible for the plasma membrane contamination that was seen in purified 








Figure 3.4 Hgt1-HA is localized to purified mitochondrial fractions. Yeast were grown 
to mid-log phase in SC media using 2% galactose as the carbon source. Prior to 
fractionation, whole cell lysates were prepared and saved as controls. The cytosol was 
separated from crude mitochondria (mito) by a series of low and high-speed centrifugation 
steps. Resulting mitochondria were density gradient purified via ultracentrifugation. 75 µg 
of protein was loaded for the whole cell and cytosolic fractions. 15 µg of crude and purified 
mitochondrial protein was added to the gel. Fractions were separated by SDS-PAGE and 
immunoblotted against HA, Pgk1 (cytosolic marker), Porin (mitochondria marker), Cpy1 




membrane tethering, we fractionated and purified mitochondria (Fig. 3.5). The resulting 
western blot showed that mitochondria purified from num1∆ yeast still contained some 
plasma membrane contamination. Thus, it seems that tethering is not responsible for this 
contamination and that the density gradient purification protocol we used is not effective 
at purifying mitochondria from plasma membrane.   
HGT1 overexpression in gsh1∆ strains does not increase GSH uptake into isolated 
mitochondria- To determine if Hgt1 is directly involved in GSH accumulation in the 
mitochondria, we measured the uptake of GSH into isolated mitochondria from GSH 
depleted cells that overexpress HGT1 (Fig 3.6). GSH depletion in yeast cells was 
accomplished by knocking out the γ-glutamylcysteine synthetase gene (GSH1), which 
catalyzes the first step in the GSH biosynthesis pathway (27). The resulting GSH1 deletion 
(gsh1∆) strain was then transformed with the HGT1 overexpression plasmid and vector 
control and grown in GSH-deficient media. Isolated mitochondria were treated with 15 
mM GSH or the buffer control for 30 minutes. GSH uptake was determined by the 
acidification of mitochondrial samples and total GSH measurement via the DTNB enzyme 
cycling assay. Our results show that the uptake of GSH into purified mitochondria from 
the surrounding buffer is similar for HGT1 overexpression strains and the vector control. 
Taken together with previous studies, we conclude that Hgt1 is not a mitochondrially 
localized protein and mitochondrial GSH pools are not directly affected by overexpression 
or deletion of the transporter. 
 
Discussion  
GSH participates in several biological functions and reduced GSH is a key factor in 









Figure 3.5 Plasma membrane contamination of purified mitochondria is not due to 
Num1 mito-ER tethering. WT and num1∆ were transformed with HGT1 overexpression 
and vector control plasmids. Cytosolic and crude mitochondria (mito) fractions were 
separated by a series of low and high-speed centrifugation steps. Resulting mitochondria 
were layered over a sucrose gradient and purified using ultracentrifugation. 75 µg of 
protein was loaded for the whole cell and cytosolic fractions. 15 µg of crude and purified 
mitochondrial protein was added to the gel. Fractions were separated by SDS-PAGE and 








Figure 3.6 HGT1 overexpression in gsh1∆ strains does not increase GSH uptake into 
isolated mitochondria. Crude mitochondria were isolated from gsh1∆ strains 
overexpressing HGT1 and the vector control. Mitochondria was layered over a 27% 
sucrose cushion at 2000 µg/mL and treated with 15 mM GSH for 30 minutes at 30 °C. 
Samples were treated with 1% SSA and GSH concentration was measured using the DTNB 




heavy metals. Mitochondrial GSH status is particularly important given that selective 
depletion of mitochondrial GSH leads to cellular injury (28). To understand the 
mechanisms that regulate mitochondrial GSH levels and redox state, it is critical to 
understand GSH transport inside the mitochondrial matrix. Two anion transporters, 
dicarboxylate and 2-oxoglutarate carriers, isolated from renal tissue were found to be 
responsible for approximately 70-80% of GSH transport into the mitochondria in 
mammalian cells. These results were based on GSH uptake studies in the presence of 
known inhibitors of each anionic carrier (10),(11). However, studies overexpressing the 
dicarboxylate and 2-oxoglutarate carriers in fused membrane vesicles of Lactococcus lactis 
contradict these findings (12). Homologues of the dicarboxylate and 2-oxoglutarate anionic 
carriers in S. cerevisiae have been identified. However, their specific role in GSH transport 
has not yet been demonstrated.  
Due to the conflicting data surrounding the proposed mitochondrial GSH transporters 
and recent reports that the Hgt1 homologue, Opt2, is dually localized to plasma and 
peroxisomal membranes, we decided to explore the role of Hgt1 in mitochondrial GSH 
import. We also set out to determine if Hgt1 is localized to subcellular organelles and 
specifically the mitochondrial membrane. Localization of Hgt1 was determined by 
overexpressing HA-tagged Hgt1. Isolation of crude cytosolic and mitochondrial fractions 
revealed Hgt1 in the mitochondria. While interesting, these data did not definitively mean 
that Hgt1 is localized to mitochondria, given that crude mitochondria isolates are often 
contaminated with vacuole, ER, and some plasma membranes. Thus, we proceeded to 
further purify crude mitochondrial fractions via density gradient ultracentrifugation. This 
purification procedure removed vacuole contamination and most of the ER found in crude 
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mitochondria. However, with this method we were not able to separate plasma membrane 
from mitochondria.  
During the cell cycle, mitochondria are partitioned from the mother cells to the 
daughter cells through a process known as tethering. Tethering plays a critical role in 
maintaining the shape and position of mitochondria, which is critical for proper function. 
The cell cortex protein, Num1, is responsible for mitochondrial inheritance and positioning 
in budding yeast by tethering the mitochondria to the inner face of the plasma membrane 
(24–26). We hypothesized that plasma membrane contamination of purified mitochondria 
was due to Num1 tethering. A genetically modified yeast with NUM1 deleted was 
fractionated and mitochondria purified. Antibodies for the plasmid membrane H+-ATPase 
Pma1 was used as a plasma membrane marker in purified mitochondria from the num1∆ 
stain. As seen in WT yeast, Pma1 contamination was not removed from the purified 
mitochondria under these conditions. Therefore, we concluded that Hgt1-HA was not 
intracellularly localized to the ER or vacuole. Secondly, mitochondrial purification using 
a sucrose gradient was not effective for determining localization of Hgt1-HA on the 
mitochondrial membrane.  
To further investigate the role of Hgt1 in mitochondrial GSH transport, we created a 
GSH1 deletion strain where HGT1 is overexpressed (gsh1∆ + HGT1). GSH1 deletion 
results in whole cell GSH depletion when GSH is omitted from the growth media (29). 
Mitochondria were isolated from the gsh1∆ + HGT1 strain and treated with 15 mM GSH. 
Cells devoid of GSH were used so that any measured GSH could be attributed to the uptake 
by Hgt1 and not cytosolic biogenesis and transport into mitochondria prior to isolation. 
When compared to the vector control, HGT1 overexpression strains had similar levels of 
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GSH uptake into mitochondria. Taken together with our localization studies, we believe 
that it is unlikely that Hgt1 is a mitochondrial transporter. Given the importance of 
mitochondrial GSH pools to many cellular functions, future studies identifying the GSH 
transporter within the mitochondrial matrix would be beneficial for understanding 
pathologies connected to changes in mitochondrial GSH. 
In this study, we also looked at the effect of Hgt1 on mitochondrial GSH pools. First, 
we employed the HGT1 overexpression plasmid in WT yeast and measured GSH 
accumulation in cytosolic and mitochondrial fractions from cells treated with 100 µM 
GSH. We found that cells under reductive stress accumulate both cytosolic and 
mitochondrial GSH. Therefore, we show that while Hgt1 may not directly import GSH into 
the mitochondria, a large influx of GSH into the cytosol increases mitochondrial GSH 
pools.  
To further elucidate the impact of HGT1 on mitochondrial GSH pools we used a HGT1 
deletion strain. Previous reports using a hgt1∆ strain showed that uptake of radiolabeled 
GSH is significantly reduced (5). Our results confirm these findings as we see that cytosolic 
GSH of hgt1∆ is lower compared to WT cells treated with 100 µM GSH. Interestingly, we 
find that mitochondrial GSH is unaffected by extracellular GSH compared to the WT 
control. Thus, it appears that mitochondria can maintain GSH pools in cells that have 
reduced cytosolic GSH. Overall, our data show that increasing the cytosolic GSH pools 
can affect GSH pools in subcellular organelles. However, reduced import has no effect of 
mitochondrial GSH. These results address the topic of subcellular cross-talk, which is 
thought to be important in maintaining redox homeostasis. Future studies focused on 
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OVEREXPRESSION OF THE YEAST HIGH AFFINITY GLUTATHIONE 




In Saccharomyces cerevisiae, depletion of glutathione (GSH) leads to increased 
sensitivity to oxidants and other toxic compounds, disruption of Fe-S cluster maturation, 
and eventually cell death. Subcellular GSH pools are maintained by intracellular 
biosynthesis and import of GSH from the extracellular environment. The physiological 
implications of disrupting the GSH1 gene encoding γ-glutamylcysteine synthetase, causing 
low levels of GSH, have been very well characterized. Recent studies have also 
demonstrated the effects of GSH overaccumulation via overexpression of the high affinity 
GSH transporter, Hgt1. However, it has not been determined how cells that shuttle between 
GSH deplete and replete conditions respond to extreme fluctuations in GSH pools. To 
study this, our lab employed a GSH deplete (gsh1∆) yeast strain engineered to overexpress 
HGT1. Interestingly, we find that HGT1 overexpression partially rescues growth in the 
absence of GSH in gsh1∆ strains. This result was dependent on the availability of cysteine 
in the growth media; however, overexpression of the high affinity cysteine transporter Yct1 
did not rescue growth in the gsh1∆ strain in a similar manner as Hgt1. Furthermore, 




thiol containing molecule, dithiothreitol, also partially restored growth in gsh1∆ cells 
overexpressing HGT1, suggesting that the rescue involves redox-dependent pathways. 
Previous studies have shown that GSH limitation in yeast leads to an iron starvation 
response that is mediated by the low iron sensing transcription factor, Aft1. Analysis of 
subcellular iron and mRNA expression of Aft1-regulated genes reveal that HGT1 
overexpression partially alleviates the iron starvation-like response of gsh1∆ cells. Taken 
together, these results suggest that HGT1 overexpression may facilitate import of other 
small thiol-containing compounds that can sustain cell growth without GSH 
supplementation in GSH-depleted yeast. These data also suggest that both thiol-redox 
regulation and iron metabolism may be important for the rescue of gsh1∆ cells by Hgt1. 
However, the specific mechanisms whereby HGT1 overexpression compensates for the 
lack of GSH are still unclear. 
 
Introduction 
  Glutathione (L-γ-glutamyl-L-cysteinylglycine, GSH) is an essential low molecular 
weight thiol in eukaryotic cells. Its ability to serve as a reducing equivalent in several 
biological reactions offers protection against reactive oxygen species (ROS), xenobiotics, 
and heavy metals. Additionally, GSH serves as an iron ligand for some Fe-S binding 
proteins involved in iron regulation and the synthesis and maturation of Fe-S cluster 
proteins. The importance of GSH is highlighted by the fact that depletion of GSH pools is 
detrimental to the health and viability of eukaryotes. In yeast, low GSH levels result in 
oxidant sensitivity, mitochondrial dysfunction, disruption of iron regulation, and limited 




the ER and disrupts iron homeostasis, leading to cell death (2). Hence, the homeostatic 
maintenance of GSH is critical.  
Two ways in which GSH pools are sustained is through intracellular synthesis and 
import from the extracellular environment. The biosynthesis of GSH occurs via a two-step 
ATP-dependent enzymatic process. In the first reaction, γ-glutamylcysteine is formed by 
γ-glutamylcysteine synthetase (Gsh1). In the second step, glycine is added to the peptide 
via GSH synthetase (Gsh2). Previous studies by Grant et al. found that γ-glutamylcysteine 
can partially compensate for GSH as an antioxidant. However, poor growth of yeast lacking 
Gsh2 (gsh2∆) in minimal media is evidence that γ-glutamylcysteine cannot fully substitute 
for the essential function of GSH (3).  
Biochemical evidence for GSH transport from the extracellular environment has 
been demonstrated in a variety of organisms ranging from bacteria to yeast and mammalian 
cells. However, the only high affinity GSH transporter identified is the plasma membrane-
localized Hgt1/Opt1 of S. cerevisiae (4). Recent reports show that overexpression of HGT1 
in media supplemented with 100 µM GSH leads to overaccumulation of both reduced 
(GSH) and oxidized glutathione (GSSG) (2). Studies using either gsh1∆ or HGT1 
overexpression strains have characterized the effects of low and high levels of intracellular 
GSH separately. However, no studies have been reported how fluctuation from GSH 
depletion to GSH overaccumulation affects subcellular redox homeostasis as well as 
cellular health and viability.  
To understand how yeast respond to GSH deplete and replete conditions, we 
overexpressed the Hgt1 transporter in a gsh1∆ strain. Surprisingly, we find that GSH-




without GSH supplementation. Since the dithiol reducing agent 1,4-dithiothreitol (DTT) 
was found to partially rescue gsh1∆ cells, we set out to determine if the thiol or thioether 
containing amino acids cysteine and methionine in synthetic complete media were 
responsible for this rescue (5). Our results show that cysteine was indeed able to sustain 
growth of gsh1∆ + HGT1 strains, both aerobically and anaerobically. This lead us to 
investigate further the findings by Bourbouloux et al. in which cysteine was shown to 
marginally inhibit the uptake of GSH from the extracellular environment by Hgt1, 
suggesting that Hgt1 can import cysteine with low specificity (4). We hypothesized that 
HGT1 overexpressing gsh1∆ cells selectively uptake cysteine from the extracellular 
environment to sustain growth.  To determine if increased cysteine uptake restores growth, 
we overexpressed the high affinity cysteine transporter, Yct1, in a gsh1∆ strain. Previous 
studies demonstrated that cells overexpressing YCT1 result in a spike of intracellular 
cysteine and cystine within an hour after addition to the medium (6, 7). Cysteine treated 
cells expressing YCT1 also display a delayed increase of key metabolites in the sulfur 
amino acid pathway, with GSH increasing 3-fold after 5 hours (7). Since only trace 
amounts of GSH are needed to sustain growth, we set out to determine if enhanced cysteine 
uptake by Yct1 can rescue gsh1∆ cells as seen with Hgt1 (8). Our results suggest that the 
rescue witnessed in HGT1 strains depleted of GSH does not involve a significant increase 
in intracellular cysteine.  
GSH has also been identified as a key player in the maturation of extra-
mitochondrial Fe-S clusters. Iron-sulfur (Fe-S) clusters are essential for a wide range of 
biological processes and disruption of Fe-S cluster biogenesis has been linked to 




S clusters begins in the mitochondrial matrix by a set of proteins termed the Fe-S cluster 
assembly (ISC) machinery. The maturation of cytosolic Fe-S clusters is dependent on the 
ISC machinery. The ISC machinery  is proposed to produce an unknown sulfur-containing 
substrate that is exported from the mitochondrial matrix with the help of GSH and the 
GSH-persulfide exporter, Atm1 (10). Depletion of GSH in yeast results in impaired 
maturation of cytosolic Fe-S proteins, iron accumulation, and the constitutive activation of 
the iron regulatory transcription factor, Aft1 (2, 5, 11). Similarly, iron regulation is 
disrupted with increased GSH in HGT1-overexpressing cells (2). Studies evaluating 
extreme changes in GSH concluded that the essential role of GSH is its involvement in Fe-
S cluster biogenesis. To investigate if rescue by Hgt1 involves iron regulation, we 
measured subcellular iron and RNA expression of Aft1-regulated genes. Interestingly, our 
data suggests that the limited rescue of gsh1∆ by HGT1 overexpression may be partly due 
to restored regulation of iron metabolism.  
 
Experimental Procedures  
Yeast Strains, Media, and Growth Conditions-Saccharomyces cerevisiae used in 
this study were derived from the wild type (WT) strain BY4741 (MATa his3Δ1 leu2Δ0 
met15Δ0 ura3Δ0). The glr1::kanMX4 deletion strain was purchased from Open 
Biosystems. Strains were grown in synthetic complete (SC) selection media (0.671% yeast 
nitrogen base without amino acids and ammonium sulfate, 2% glucose, with appropriate 
drop-out mix) (US Biological) or in supplemented minimal media, termed 6AA/B media 
(0.671% yeast nitrogen base without amino acids and ammonium sulfate, 2% glucose, 




mg/L adenine, 60 mg/L leucine, 30 mg/L lysine, 20 mg/L histidine, 20 mg/L tryptophan, 
and 20 mg/L methionine). Where required, media was solidified using 2% agar. All assays 
were done using exponentially grown cells.  
 Plasmid Construction and Transformation-The gsh1∆ strain was created by 
chromosomal replacement of GSH1 with an amino acid marker gene. Briefly, the GSH1 
deletion plasmid (pGSH1KO) was prepared by cloning upstream and downstream regions 
of the GSH1 gene using the primers listed in Table 3.1 (see Chapter 3). The upstream PCR 
product was digested with BamHI and EcoRI and the downstream with SalI and EcoRI. 
Both digested PCR products were ligated in a trimolecular reaction into the BamHI and 
SalI sites of the yeast integrating plasmid pRS403 (HIS3 selection). After linearization with 
EcoRI, the integrating deletion plasmid was inserted into the genome of WT BY4741 yeast 
via homologous recombination. The pTEF-416-HGT1 plasmid described earlier (CEN 
URA3, TEF1 promoter driving HGT1 expression) was used for HGT1 overexpression (4). 
Yeast transformations were performed by standard lithium acetate protocols (12). GSH 
deplete (gsh1∆) strains were selected on 25 µM GSH SC (-HIS) plates after transformation 
with pGSH1KO and 0.1 µM GSH SC (-HIS, -URA) when the pTEF-416 and pTEF-416-
HGT1 plasmids were transformed. 
Subcellular fractionation-Yeast cells were grown aerobically to mid-log phase in 
SC selection medium with 2% glucose. Mitochondrial and post-mitochondrial supernatant 
(PMS) fractions were obtained as previously described by converting cells to spheroplasts 
followed by gentle lysis using a loose-fitting Dounce homogenizer and differential 




reduction of endogenous disulfides and protease inhibitors were not included in buffers 
(13). 
GSH/GSSG Assay-Total GSH (reduced GSH and oxidized GSSG) was measured 
in whole cell, PMS, and mitochondrial extracts using the 5,5-dithiobis(2-nitrobenzoic 
acid)-GSSG reductase cycling assay as previously described (14). For whole cells 
measurements, 2 x 107 cells (or 2 x 109 cells for GSH deplete strains) were harvested via 
centrifugation at 12000 rpm for 10 seconds. Cell pellets were washed twice with water. 
Lysis was performed by vigorous vortexing using 1% 5-sulfosalicylic acid (wt/vol) and 
glass beads. The resulting supernatant containing GSH was incubated on ice for 30 minutes 
and cleared via centrifugation. PMS and mitochondrial fractions were prepared as 
described above. Protein content was measured using the Bradford method with bovine 
serum albumin as a calibration standard. Subcellular fractions were incubated with 1% 5-
sulfosalicylic acid on ice for 30 minutes, fractions were spun at 13000 g at 4 °C, and the 
supernatant containing total GSH was transferred to sterile microcentrifuge tubes.  
Western blots- Immunoblotting was used to check gene expression within yeast 
extracts. Recombinant yeast Gsh1 was expressed in E. coli and the purified enzyme was 
used to create the monoclonal Gsh1 (1:1000, rabbit IgG, IRDye, LI-COR, Lincoln, NE) 
antibody used in this study (15). The Pgk1 (1:10,000, mouse IgG monoclonal, Invitrogen) 
antibody was used as a loading control.  
Growth Curves in Liquid Media and Solid Media Spot Tests-To determine the 
growth pattern of yeast strains in liquid media, cells were plated on SC(-URA) 2% glucose 
plates containing 0.05 µM GSH for 2-3 days. Each strain was later inoculated into fresh 




determined in sterile 96-well plates using a Synergy H1 plate-reader and Gen5 Software 
2.09. For growth on plates, strains were harvested from SC(-URA) 2% glucose plates 
containing 0.05 µM GSH and resuspended in sterile water to OD600 of 1. The cells were 
serially diluted to 1:10, 1:100, and 1:1000. The resuspended cells were spotted on SC or 
6AA/B selection plates and incubated at 30 °C aerobically or anaerobically for 2 days.  
Intracellular Iron Analysis- Intracellular iron of cytosolic and mitochondrial 
extracts was measured using a PerkinElmer PinAAcle 900T graphite furnace atomic 
absorption spectrometer according to the manufacturer’s instructions. Yeast cells were 
grown on SC(-URA) 2% glucose plates containing 1 µM GSH for 2-3 days. Cells were 
inoculated into fresh SC(-URA) 2% glucose media with or without GSH and grown 
overnight until reaching mid-log phase. Cytosolic and mitochondrial fractions were 
prepared as described above. Extracts were diluted in Milli-Q water and measurements 
performed. Protein content was measured by standard Bradford analysis and iron content 
was standardized per mg protein (15). 
 
Results 
Confirmation of gsh1∆ + vector and gsh1∆ + HGT1 phenotypes- To study the 
effects of GSH fluctuations, we created a gsh1∆ strain that constitutively uptakes GSH 
from the extracellular environment via HGT1 overexpression. Due to the essential nature 
of GSH, gsh1∆ strains were pre-grown on SC plates supplemented with 0.1 µM GSH and 
cultured in SC liquid medium with 0.1 µM GSH until reaching mid-log phase. Western 
blot analysis confirmed that GSH1 was knocked out of both gsh1∆ + vector and gsh1∆ + 









Figure 4.1. Confirmation of gsh1∆ + vector and gsh1∆ + HGT1 phenotypes. (A) 
Western blot analysis of whole cell extracts (75 µg protein loaded) shows that Gsh1 is not 
expressed in gsh1∆ strains. (B) Whole cell GSH depletion is confirmed via the DTNB 
spectrophotometric assay in gsh1∆ + vector and gsh1∆ + HGT1 strains pre-grown on SC 
+ 0.1 µM GSH plates and cultured in SC + 0.1 µM GSH medium overnight. Data shown 
are the means and standard deviation (SD) of 2-3 biological replicates. ND, not detected 




overaccumulate GSH when exposed to GSH, we measured the steady state levels of total 
GSH in gsh1∆ + vector and gsh1∆ + HGT1 with or without GSH treatment (Fig. 4.1B) 
(2).   
As expected, GSH was depleted in both gsh1∆ + vector and gsh1∆ + HGT1 
untreated strains. Incubation with 100 µM GSH for 30 minutes resulted in GSH 
overaccumulation in gsh1∆ + HGT1 in a similar manner as WT + HGT1. However, total 
intracellular GSH was lower in treated gsh1∆ + HGT1 compared to WT. Taken together, 
we successfully created a yeast genetic model to monitor extreme GSH fluctuations.  
HGT1 overexpression rescues the growth defect of gsh1∆ cells and causes 
increased sensitivity to GSH and GSSG- After confirming the phenotypes of gsh1∆ + 
vector and gsh1∆ + HGT1, we accessed the requirement of GSH for growth. All strains  
were pre-grown in SC medium containing 0.05 µM GSH. Serial dilution and spotting onto 
SC plates showed that gsh1∆ + HGT1 grows without added GSH (Fig. 4.2A). These results 
suggest that overexpression of HGT1 rescues the growth defect of gsh1∆ strains. The 
rescue was also apparent when cells were grown in liquid media (Fig. 4.2B). Kumar et al. 
report that GSH concentrations higher than 20 µM impedes growth of HGT1 expressing 
cells (2). We confirmed this phenotype in WT + HGT1. Interestingly, we see that 
concentrations as low as 5 µM are toxic for gsh1∆ + HGT1. We also tested the sensitivity 
of WT + HGT1 and gsh1∆ + HGT1 to GSSG. GSSG is equal to two molecules of GSH 
(16). Our data suggests that HGT1 strains are slightly less sensitive to GSSG in liquid 
media (compare 2.5 µM GSSG in Fig 4.3B with 5 µM GSH in Fig. 4.2B). This may be due 
to Hgt1 having a higher affinity for GSH compared to GSSG leading to lower GSSG uptake 










Figure 4.2. HGT1 overexpression rescues the growth defect of gsh1∆ cells and causes 
increased sensitivity to GSH. (A) WT and gsh1∆ strains were pre-grown on SC + 0.05 
µM GSH selection plates. Yeast strains were serially diluted and spotted on SC glucose 
media with increasing GSH concentrations and grown anaerobically for 2 days at 30 °C 
(B) Growth and sensitivity to GSH was analyzed by using a Synergy H1 plate-reader. The 









Figure 4.3. WT and gsh1∆ strains overexpressing HGT1 are sensitive to extracellular 
GSSG. (A) WT and gsh1∆ strains were pre-grown on SC + 0.05 µM GSH selection plates. 
Yeast strains were serially diluted and spotted on SC glucose media with increasing GSSG 
concentrations and grown anaerobically for 2 days at 30 °C (B) Growth and sensitivity to 
GSSG was analyzed by using a Synergy H1 plate-reader. Growth curves are reported as 




Overnight incubation of gsh1∆ strains with increasing GSH concentrations led to 
less GSH accumulation in gsh1∆ + HGT1- Due to the unexpected growth patterns of gsh1∆ 
+ HGT1, intracellular GSH was assessed in cells grown with various GSH concentrations.  
In this study, the minimum amount of GSH necessary for growth of both gsh1∆ + vector 
and gsh1∆ + HGT1 cells cultured from SC + 0.05 µM GSH plates was 0.1 µM GSH. When 
grown with increasing, relatively low GSH concentrations, HGT1 overexpression had no 
effect on intracellular GSH in WT strains (Fig. 4.4A). While GSH levels were difficult to 
detect in gsh1∆ cells cultured in concentrations less than 1 µM, detectible GSH 
measurements show that gsh1∆ + HGT1 accumulate less GSH in overnight growth than 
the vector control (Fig. 4.4B). As shown by Kumar et al., HGT1 cells treated with GSH 
increase shortly after adding GSH to the growth media and decrease over time. The authors 
contributed the decrease to the degradation of GSH by the γ -glutamyl transpeptidase (γ-
GT)-independent Dug1–Dug2–Dug3 pathway (2). Therefore, our data for WT + HGT1 
coincide with the published literature. It is possible that the low level of GSH rapidly 
imported by HGT1 overexpression is degraded quickly by the Dug pathway, while slower 
controlled import with native HGT1 expression avoids this degradation. 
Kinetic measurements of GSH content in gsh1∆ + vector and gsh1∆ + HGT1- To 
determine if GSH catabolism is responsible for low intracellular GSH measurements in 
gsh1∆ + HGT1, we monitored GSH levels over time for cells treated with 100 µM GSH 
(Fig. 4.5). As seen in previous reports using WT yeast, GSH levels in gsh1∆ strains 
overexpressing HGT1 accumulate high levels of GSH within one hour of treatment and 
drop after two hours (2). GSH levels in gsh1∆ + vector increase slightly and stay constant 






Figure 4.4. Overnight incubation of gsh1∆ strains with increasing GSH 
concentrations led to less GSH accumulation in gsh1∆ + HGT1. Yeast strains were pre-
grown on SC + 0.05 µM GSH selection plates and inoculated in SC media with various 
concentrations of GSH. Cells were acidified with 1% SSA and whole cell GSH in (A) WT 
and (B) gsh1∆ strains containing vector and HGT1 plasmids was measured using the 
DTNB cycling assay. Data shown are means for four independent experiments with error 








Figure 4.5. Kinetic measurements of GSH content in gsh1∆ + vector and gsh1∆ + 
HGT1. Kinetics of cellular GSH accumulation was monitored in cells grown using SC + 
0.05 µM GSH selection plates and liquid cultures overnight in SC media with 0.1 µM GSH. 
100 µM GSH was added to exponentially growing cells at time 0 and cell aliquots were 





hours GSH levels in gsh1∆ + HGT1 were similar, if not slightly lower than the vector 
control. This observation could explain the reduced GSH levels after overnight growth for 
gsh1∆ + HGT1 vs. gsh1∆ + vector strains. However, additional experiments over a longer  
time course and possibly lower GSH concentrations are required to determine if these 
differences between strains after overnight growth are significant.  
HGT1 overexpression partially rescues the growth defect of gsh1∆ strains- Due to 
its cellular abundance ranging from 3 mM to 10 mM and its ability to serve as a cofactor 
in many redox reactions, GSH is thought to be an important redox buffer in the cell. 
Therefore, we wanted to investigate the rescue of gsh1∆ by HGT1 overexpression in 
different redox and nutrient environments. We observed that the gsh1∆ + HGT1 strain can 
grow almost as well as WT in aerobic and anaerobic conditions (Fig. 4.6A). Therefore, the 
potential for oxidant production under aerobic conditions has little effect on the ability of 
HGT1 to restore growth in gsh1∆. Next, we wanted to see if the availability of amino acid 
played a role in viability of gsh1∆ + HGT1. We therefore monitored growth of strains on 
6AA/B medium, defined as minimal medium with only six amino acids and nucleobases 
that are essential for yeast growth added at relatively low concentrations. In comparison, 
SC medium only lacks a single or a few amino acids that allows maintenance of 
transformed plasmids (see methods section) (18). Consistent with previous reports neither 
gsh1∆ + vector nor gsh1∆ + HGT1 are able to grow. Therefore, it seems that HGT1 only 
partially rescues gsh1∆ and this rescue is related to nutrient availability (Fig. 4.6B-C). 
Cysteine is a key amino acid for rescue of gsh1∆ when HGT1 is overexpressed- Of 
the twenty common amino acids, cysteine is one of the least abundant. Yet, the free 










Figure 4.6 HGT1 overexpression partially rescues the growth defect of gsh1∆ strains. 
(A) HGT1 overexpression in GSH depleted (gsh1∆) cells are fully viable without GSH 
supplementation on SC plates under both aerobic and anaerobic conditions. GSH depleted 
strains expressing either an empty vector or an HGT1 overexpression plasmid are unable 
to grow on 6AA/B plates after 48 hours (B), nor in liquid media after 24 hours of growth 





cofactors, including GSH (19). Since SC medium contains cysteine, we set out to determine 
if cysteine is responsible for the rescue of gsh1∆ by HGT1. Indeed, cysteine resulted in 
improved growth of gsh1∆ + HGT1 strains on 6AA/B media under anaerobic conditions.  
However, this rescue did not occur under aerobic conditions, suggesting that cysteine alone 
cannot replace the function of GSH in minimal media under mild oxidative stress 
conditions (Fig. 4.7A). Of the additional amino acids found in SC media tested, no other 
individual amino acid alone could partially restore growth, including the thioether-
containing amino acid methionine (Fig. 4.7B). However, gsh1∆ + HGT1 cells grew better 
on SC medium compared to 6AA/B + Cys medium, particularly in aerobic conditions, 
suggesting that the other amino acids, nucleobases, and other nutrients in SC medium 
collectively improve the viability of gsh1∆ + HGT1 cells independently of cysteine. To 
test this, we used SC media lacking uracil, the amino acid selection marker, and cysteine 
(Fig. 4.8). The gsh1∆ + HGT1 was able to grow in SC media lacking cysteine, although at 
a slower rate compared to SC media with cysteine added back. These results further 
confirm that nutrient availability is important for growth of gsh1∆ cells expressing HGT1, 
with cysteine playing a key role. To further test a redox-dependent mechanism of rescue, 
we investigated the effects of the sulfhydryl-containing reducing agent dithiothreitol (Fig. 
4.9). Dithiothreitol was able to partially restore growth under aerobic conditions but was 
toxic to all strains under anaerobic conditions at the same concentration (data not shown). 
Thus, our results suggest that the requirement for GSH is partially redox-dependent and 
HGT1 overexpression helps meet the redox needs of the cell.  
 gsh1∆ + HGT1 strains are viable after 48 hours without GSH 










Figure 4.7 Cysteine is a key amino acid for rescue of gsh1∆ when HGT1 is 
overexpressed. Yeast cells pre-grown on SC plates with 0.05 µM GSH for 2 days were 
spotted on (A) 6AA/B plates with or without 85.6 mg/L cysteine under aerobic and 










Figure 4.8 Cysteine improves growth of gsh1∆ + HGT1 cells in SC media. Growth 
curve analysis in SC media shows that cysteine is a key amino acid for rescue in SC media. 










Figure 4.9. DTT partially restores growth of gsh1∆ + HGT1 strains on minimal 6AA/B 
media. (A) Yeast cells pre-grown on SC plates with 0.05 µM GSH for 2 days were spotted 




monitored for 48 hours at different starting ODs. Ayer et al. reported that gsh1∆ cells 
switched to GSH-deficient media undergo 8-10 cell divisions before GSH pools are too 
diluted to support further growth (1). Therefore, we tested if gsh1∆ + HGT1 cells would 
continuously grow for longer than 24 hours with >10 divisions without GSH addition. Cells 
harvested from SC plates supplemented with 0.05 µM GSH were grown for 48 hours in 
SC media without GSH. Here, we show that gsh1∆ + HGT1 cells grow similar to WT and 
growth exceeds 10 divisions regardless of the starting OD (Fig. 4.10A). After growth in 
SC media for 48 hours, gsh1∆ + HGT1 cells and the WT control were plated on 6AA/B 
minimal media with or without cysteine. We confirm that cysteine can still rescue cells 
completely devoid of GSH (Fig. 4.10B).  
 Cysteine uptake is not responsible for growth of gsh1∆ + HGT1 strains in SC 
media- Our findings that cysteine is able to render gsh1∆ + HGT1 viable in minimal media 
was not surprising as previous studies have shown that gsh1∆ growth can be partially 
restored by reducing agents (20). Furthermore, cysteine marginally inhibits Hgt1 uptake of 
GSH, suggesting that it may serve as a weak-binding Hgt1 substrate (4). Thus, we 
hypothesized that HGT1 overexpression leads to increased cysteine import in the absence 
of extracellular GSH. To test this hypothesis, we measured intracellular cysteine levels of 
strains grown overnight in SC media. However, we find that cysteine levels in gsh1∆ + 
HGT1 were similar or only slightly higher than gsh1∆ + vector and WT controls (Fig. 
4.11A). To further our studies, we determined if cysteine availability played a role in gsh1∆ 
rescue by overexpressing the Yct1 transporter in WT and gsh1∆ strains. We show that 









Figure 4.10 gsh1∆ + HGT1 strains are viable after 48 hours without GSH 
supplementation. (A) Yeast cells were pre-grown on SC plates with 0.05 µM GSH for 2 
days, diluted to various starting ODs in sterile water, and grown in SC selection media for 
48 hours. Growth is represented as the mean and standard deviation of 2 biological 
replicates. (B) After growing WT and gsh1∆ strains for 48 hours in SC selection media 
with repeated dilutions to maintain exponential growth, cells were spotted on 6AA/B plates 









Figure 4.11. Cysteine uptake is not responsible for growth of gsh1∆ + HGT1 strains 
in SC media. (A) Yeast strains were pre-grown on synthetic complete plates with 1 µM 
GSH for 2 days. Cells were cultured overnight in SC selection media.  Intracellular cysteine 
was measured by liquid chromatography-tandem mass spectrometry (measurements were 
done by Michel Toledano’s group). (B) YCT1 strains and controls were pre-grown on SC 
+ 0.05 µM GSH selection plates and growth was assessed in liquid SC media with no GSH. 





(Fig. 4.11B). Taken together, these results suggest that increased cysteine availability is 
not the cause of gsh1∆ + HGT1 rescue in media without GSH.  
Subcellular GSH measurements of gsh1∆ + vector and gsh1∆ + HGT1 strains 
grown in various GSH concentrations- During oxidative phosphorylation, ROS are 
generated as by-products due to the incomplete reduction of molecular oxygen to water. 
This process occurs in the mitochondria, making this organelle subject to oxidative stress. 
Mitochondrial GSH is thought to play a protective role against the deleterious effects of 
oxidants. Evidence for the vital role of GSH to mitochondrial function in yeast is shown in 
research conducted by Ayer et al. The authors report that after one to two divisions gsh1∆ 
cells become irreversibly respiratory incompetent and after 5 divisions approximately 75% 
of mitochondrial DNA is lost. Despite these effects, GSH depleted cells still can undergo 
approximately 8-10 divisions. This growth is associated with the consumption of pre-
accumulated reserves of GSH (1). Given the importance of mitochondrial GSH and our 
data showing that gsh1∆ + HGT1 have less intracellular GSH than gsh1∆ + vector after 
overnight growth, we hypothesized that pre-accumulated reserves of GSH are stored in the 
mitochondria aiding in cell growth. To test this hypothesis, we grew gsh1∆ + vector and  
gsh1∆ + HGT1 overnight in various concentrations of GSH. Cytosolic and mitochondrial 
fractions were tested for subcellular GSH. We find that steady-state levels of cytosolic 
GSH are similar in gsh1∆ + vector and gsh1∆ + HGT1 strains in low and high 
concentrations of external GSH (Fig. 4.12A). Similarly, mitochondrial GSH is not 
significantly different for cells cultured with increasing GSH concentrations (Fig. 4.12B). 









Figure 4.12. Subcellular GSH measurements of gsh1∆ + vector and gsh1∆ + HGT1 
strains grown in various GSH concentrations. Yeast strains were pre-grown on SC + 
0.05 µM GSH selection plates and inoculated in SC media with various concentrations of 
GSH. Cells were acidified with 1% SSA. (A) Cytosolic and (B) mitochondrial GSH levels 
of gsh1∆ strains were measured using the DTNB cycling assay. Data shown are the means 




gsh1∆ + HGT1 cells can grow on fermentable, partially fermentable, and non-
fermentable carbon sources– Previous studies assessing mitochondrial respiration and cell  
growth found that gsh1∆ undergo fewer divisions when grown using glycerol and ethanol 
as a carbon source (1). These data suggest that there is a greater need for GSH when gsh1∆ 
cells are grown under non-fermentative conditions. Therefore, we tested if carbon source 
affects the growth of gsh1∆ + HGT1 in the absence of GSH supplementation. We find that 
HGT1 rescues gsh1∆ cells irrespective of carbon source. Yet, gsh1∆ + HGT1 appears to 
grow somewhat slower in glycerol (Fig. 4.13A). Divisions cannot be measured using spot 
tests. Therefore, growth was also analyzed in liquid media. Cells were grown in SC liquid 
media for 48 hours containing 2% glucose and SC containing 3% glycerol + 1% ethanol. 
In fermentative conditions, gsh1∆ + HGT1 cells reach a final OD600 similar to that of WT 
after 48 hours. Non-fermentative conditions resulted in decreased growth of all cells and 
gsh1∆ + HGT1 grew slower than the WT controls (Fig. 4.13B). Nevertheless, HGT1 
expressing cells did not stop dividing after 48 hours. These results imply that external GSH 
is not absolutely required for continued growth under non-fermentative conditions. 
Deletion of GLR1 does not impact the rescue of gsh1∆ by HGT1 overexpression- 
GSSG reductase (Glr1) is a cytosolic and mitochondrial-localized oxidoreductase that 
converts oxidized GSSG to reduced GSH using NADPH as a reducing equivalent (21). 
Deletion of GLR1 results in mild oxidative stress due to elevated GSSG. Gostimskaya et 
al. found that Glr1 is important for gsh1∆ strains to recover from GSH depletion and 
mitochondrial Glr1 is more critical for growth restoration than the cytosolic isoform (22). 
Therefore, we set out to determine if deletion of GLR1 affected the rescue of gsh1∆ strains 









Figure 4.13. gsh1∆ + HGT1 cells can grow on fermentable, partially fermentable, and 
non-fermentable carbon sources. Yeast cells were pre-grown on synthetic complete 
plates with 0.05 µM GSH for 2 days. (A) Strains were then serially diluted and spotted on 
SC plates containing 2% glucose, 2% galactose, or 3% glycerol and placed in a 30 °C 
incubator aerobically for 2 days. (B) Growth was monitored for 48 hours for cells grown 
in SC media containing 2% glucose (SC-Glu) and SC media containing 3% glycerol + 1% 





of glr1∆gsh1∆ as efficiently as gsh1∆ (Fig. 4.14). These data suggest that maintaining a 
high GSH:GSSG ratio is not critical for viability of gsh1∆ + HGT1. 
Defects in iron regulation are partially rescued by HGT1 overexpression in a 
gsh1∆ strain- Iron regulation in Saccharomyces cerevisiae is controlled by the paralogous 
transcriptional activators, Aft1 and Aft2. Iron deficiency activates Aft1 and Aft2, causing 
the proteins to move from the cytosol to the nucleus. Inside the nucleus, the transcription 
factors induce the expression of iron regulon genes involved in the uptake of iron (FET3, 
FTR1, FRE1, and FRE2), and siderophores (ARN1-4 and FIT1-3) (23–25). Defective Fe-S 
cluster biogenesis leads to the constitutive activation of Aft1(26, 27). GSH depletion in 
cells causes Aft1 activation, iron accumulation, and upregulation of iron regulatory genes. 
Overaccumulation of GSH results in a phenotype much like that of gsh1∆ (2). Therefore, 
we wanted to determine the impact that HGT1 overexpression has on iron metabolism in 
GSH depleted cells. To test this, cells were grown in SC + 1 µM GSH plates and transferred 
to SC media for overnight growth without GSH. We find that cytosolic iron is increased 
about 2X in gsh1∆ + vector while gsh1∆ + HGT1 has similar iron as WT strains (Fig. 
4.15A). As seen in previous studies, mitochondrial iron increases significantly with GSH 
depletion (15). Here, we report a ~16X increase in mitochondrial iron in gsh1∆ + vector 
compared to WT. While the gsh1∆ + HGT1 strain also accumulates mitochondrial iron,  
levels are significantly lower than gsh1∆ + vector having a ~10X increase compared to 
WT (Fig. 4.15B). These results imply that HGT1 overexpression helps gsh1∆ cells regulate 
iron more efficiently. To further test this theory, mRNA levels were measured for FET3 
and FIT3 genes. As expected, mRNA levels for both genes are increased in gsh1∆ + vector 








Figure 4.14 Deletion of GLR1 does not impact the rescue of gsh1∆ by HGT1 
overexpression. Yeast cells were pre-grown on synthetic complete plates with 0.05 µM 
GSH for 2 days. The indicated strains were then serially diluted and spotted on SC, 6AA/B, 










Figure 4.15. Defects in iron regulation are partially rescued by HGT1 overexpression 
in a gsh1∆ strain. Yeast were pre-grown on SC plates with 1 µM GSH for 2 days and 
cultured overnight in SC selection media. (A) Cytosolic and (B) mitochondrial iron was 
measured by atomic absorption spectroscopy. (C) Quantitative RT-PCR results for FET3 
and FIT3 mRNA levels were measured in WT and gsh1∆ strains. Data shown represents 
3-8 independent experiments with error bars representing SD. RT-qPCR measurements 




in gsh1∆ + HGT1 compared to gsh1∆ + vector. Nevertheless, mRNA levels are still 
relatively high compared to WT (Fig. 4.15C). Thus, iron measurements together with RT-
qPCR results confirm that the mechanism of rescue by HGT1 is partly due to modest 
recovery of iron regulation.  
 
Discussion 
The dependency of eukaryotic cells on intracellular GSH has been very well 
characterized using gsh1∆ strains. These studies have shown that GSH is critical for 
maintaining mitochondrial integrity and the maturation of extra-mitochondrial Fe-S cluster 
proteins (4, 11, 26). After the discovery of Hgt1, the consequence of high intracellular GSH 
was also accessed (2, 4). Nevertheless, these extreme changes in GSH were studied using 
different strains. Here, we present for the first time a model that explores the ability of cells 
to fluctuate between low and high GSH by overexpressing HGT1 in gsh1∆.  We report that 
HGT1 overexpression can rescue the growth defect of GSH deficiency. This rescue was 
seen in SC media, which contains all amino acids and nucleobases except ones needed for 
plasmid selection. We also looked at the ability of gsh1∆ + HGT1 strains to grow on 
minimal 6AA/B media. Interestingly, gsh1∆ + HGT1 was not viable in 6AA/B media 
without added GSH. This observation prompted us to investigate which component of SC 
media amino acids were responsible for the growth of gsh1∆ + HGT1 strains. Since the 
function of GSH is dependent on the redox-active cysteine, we tested the influence of 
cysteine on growth (19). We find that cysteine rescues both gsh1∆ + vector and gsh1∆ + 
HGT1, anaerobically. However, cysteine more effectively restores growth of gsh1∆ + 




growth using the sulfur-containing amino acid methionine. Neither methionine or other 
amino acids found in SC media were able to restore growth of gsh1∆ + vector or gsh1∆ + 
HGT1. Therefore, we conclude that the rescue observed by HGT1 is dependent on nutrient 
availability and is only a partial rescue.  
To understand the mechanism of rescue, we first considered that growth in SC 
media could be fulfilling the thiol-redox needs of the cell. Thus, in addition to looking at 
cysteine we determined how well gsh1∆ + vector and gsh1∆ + HGT1 respond to DTT. 
Contrary to our results with cysteine, DTT was able to rescue cells under aerobic conditions 
while cysteine restores growth anaerobically in 6AA/B media. These results can be 
explained by the fact that DTT is a stronger reductant than cysteine due to the second 
sulfhydryl group. DTT can, therefore, offer greater protection against oxidants. However, 
when grown anaerobically DTT may create an overly reducing intracellular environment 
leading to cell death. The restoration of growth using reducing agents in 6AA/B was more 
profound in gsh1∆ + HGT1 than gsh1∆ + vector. Thus, the mechanism for rescue may be 
partly due to enhanced thiol-redox control. 
GSH is thought to be essential due to its involvement in maintaining mitochondrial 
integrity (11, 22). Therefore, we proposed that pre-accumulated GSH may be redistributed 
into the mitochondria offering protection against the deleterious effects of GSH limitation. 
To test this idea, subcellular GSH levels were measured. We did not see a significant 
difference in cytosolic and mitochondrial GSH. Since GSH depletion leads to respiratory 
incompetency which has been associated with less cell divisions in gsh1∆, we tested the 
ability of gsh1∆ + vector and gsh1∆ + HGT1 to grow under fermentative and non-




+ HGT1 from dividing in SC media. Thus, we do not believe that the rescue of gsh1∆ by 
HGT1 is specific to its involvement in mitochondrial function. 
The role of GSH in Fe-S cluster assembly has been proposed as its primary function 
and the reason GSH is essential for viability (2). A characteristic phenotype of GSH 
depletion is iron accumulation, particularly in the mitochondria. Therefore, we measured 
subcellular iron in gsh1∆ strains grown overnight without GSH. We found that 
overexpression of HGT1 in gsh1∆ cells results in reduced iron in both the cytosol and 
mitochondria. However, iron levels in gsh1∆ + HGT1 are still higher than WT strains. We 
also measured the mRNA levels of FET3, encoding a multicopper oxidase required for 
ferrous iron uptake and FIT3, encoding a mannoprotein responsible for retention of 
siderophore-iron in the cell wall. The mRNA levels of both genes were lower in gsh1∆ + 
HGT1 than the vector control. Yet, FET3 and FIT3 mRNA expression was still upregulated 
in the gsh1∆ + HGT1 strain. These data imply that HGT1 overexpression helps gsh1∆ cells 
regulate iron metabolism. Taken together with our studies showing that reductants more 
efficiently rescued the gsh1∆ + HGT1 strain in minimal 6AA/B, we conclude that HGT1 
overexpression helps gsh1∆ meet the redox and iron homeostatic needs of the cell. 
Nevertheless, more work is required to define the specific molecular mechanisms at play 
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This chapter describes experimental details used to obtain results specifically for 
this dissertation. Here, you will find tips for analyzing genetically modified strains and 
information about plasmids used for this study. All procedures were adapted from 
published protocols to obtain results for our purposes. Techniques discussed in detail are 
small-scale mitochondria isolation, the glutathione (GSH)/ glutathione disulfide (GSSG) 
assay, GSH uptake into isolated yeast mitochondria, mitochondrial purification, 
construction of deletion plasmids, and monitoring growth of yeast using the Synergy H1 
plate reader.  Isolation of mitochondria from other subcellular fractions was based on 
previously described methods (1). Depending on the subsequent analysis of organelles, the 
fractionation process was altered for data interpretation. To measure GSH and GSSG from 
whole cell and subcellular compartments, we utilized the 5,5′-dithiobis(2-nitrobenzoic 
acid) (DTNB) colorimetric enzyme cycling assay (2, 3). Localization studies on purified 
mitochondria were done using methods published by Meisinger et al. (4). GSH uptake into 
yeast mitochondria was modified from the Shertzer group (5). Construction of gene 
disruption plasmids was accomplished by standard cloning procedures. Lastly, the method 




Small Scale Mitochondria Isolation 
Isolation of cytosolic and mitochondrial fractions was routinely used in conjunction 
with other assays to analyze biological changes in each compartment.  To prepare extracts 
for analyzing glutathione and iron content, the mitochondrial isolation protocol from Daum 
et al. was modified (1). For instance, protease inhibitors were omitted prior to separation 
of cytosolic and mitochondrial fractions since prevention of protein hydrolysis was not 
critical for GSH and iron measurements.  In addition, the culture volume was increased 
when growing gsh1∆ strains for GSH:GSSG analysis because the concentrations of GSH 
and GSSG are very low in these strains. The resuspension volume for isolated mitochondria 
in buffer was also adjusted for gsh1∆ samples used for GSH analysis.  
 
Buffers Needed (sterile filter or autoclave buffers and store at 4°C):   
SOR buffer: 1.2 M sorbitol, 20 mM Hepes, pH 7.5 
SM buffer:  250 mM sucrose, 10 mM MOPS, pH 7.2 
 
Enzyme Stocks 
Zymolyase 20T: 20 mg/mL in H2O (zymolyase was prepared before use and stored at – 
20 °C. The enzyme is more effective if it is thawed from a frozen stock) 
 
Fractionation Protocol  
1. Grow cells overnight in 50-100 mL culture (SC or YPD) to mid-log phase. (Larger 
cultures of approximately 300-500 mL were used when working with gsh1∆ strains 
to obtain enough mitochondria to measure GSH.) 
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2. Harvest cells at 3000 rpm for 5 min. 
3. Pre-weigh 1.5 mL microcentrifuge tubes and record values. 
4. Pour off supernatant (SN), wash cell pellet in 1 mL H2O and transfer to pre-weighed 
microcentrifuge tubes. 
5. Spin 10 s at 12000 rpm. Aspirate off SN. 
6. Wash cells with 1 mL SOR and spin 10 s at 12000 rpm. 
7. Aspirate off the SN and measure the net weight of the cell pellet. 
8. Resuspend pellet in SOR buffer (1 mL / 150 mg cells).  
9. Add 3 mg of zymolyase per gram of cells.   
10. Mix by inverting 5 times and incubate in 30 °C water bath for 30 min to 1 hr.   
11. Check spheroplasts after 45-50 min by adding 10 µL into a plastic cuvette and flush 
with 1 mL H2O. In another cuvette, flush 10 µL with 1 mL SOR buffer. If the cell 
wall of the yeast is no longer intact, the spheroplasts should lyse in H2O but not in 
SOR buffer. Therefore, the sample should look clear in water and cloudy in SOR.  
12. Spin samples at 3500 rpm for 5 min at 4 °C. Aspirate off the SN. 
13. Wash spheroplasts with 1 mL SOR buffer. (Care should be taken at this step in 
order to avoid bursting the spheroplasts.)   
14. Spin for 5 min at 3500 rpm at 4 °C and aspirate off the SN.   
15. Resuspend the spheroplasts in SM buffer (2 µL SM buffer per mg cells). Samples 
should be kept on ice from this step forward to prevent protein degradation.   
16. Add phenylmethanesulfonyl fluoride (PMSF) to a final concentration of 0.5 mM 
and protease inhibitors at 1:100 dilution to the SM buffer of samples used for 
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western blot analysis. (This step is omitted when fractions are used to measure 
intracellular GSH/GSSG and iron.) 
17. Disrupt the plasma membrane of the spheroplasts with 30 strokes in a 1-mL Dounce 
homogenizer using a loose-fitting pestle. 
18. Spin 5 min at 3000 rpm at 4 °C and carefully transfer SN to a new tube. 
19. Repeat step 18 with the SN to completely remove all pellet debris. 
20. Measure the volume of SN extract after the second spin and record.   
21. Save some of this SN extract (total extract) for western blot analysis if desired. 
22. Spin remaining total extract at 12000 rpm for 10 min at 4 °C.    
23. Transfer SN containing the post-mitochondrial supernatant to a new tube. 
24. Gently wash the pellet comprised of crude mitochondria with 500 µL SM buffer.  
25. Spin at 12000 rpm for 10 min at 4 °C and aspirate off the SN.   
26. Resuspend crude mitochondrial pellet in desired volume of SM buffer. (For western 
blot analysis mitochondria were resuspended in 1/5 volume of the total extract and 
protease inhibitors were included in the SM buffer.) 
27. Measure protein concentration of subcellular extract using the Bradford assay. 
  
Note: When measuring GSSG in the mitochondria of gsh1∆ strains, more concentrated 
mitochondria are needed. Therefore, mitochondria were resuspended in a final volume of 






GSH/GSSG Assay using Synergy H1 Plate reader  
The GSH/GSSG assay described here was developed with the help of Malini Gupta 
to measure GSH and GSSG using a Synergy H1 Plate reader. Here, we successfully 
measured yeast lysates using the procedures outlined by Rahman et al. (2). Whole cell 
lysates were made according to published methods by Cuozzo et al. (6). In order to 
accurately measure GSSG, we used undiluted 2-vinylpyridine according to Cuozzo et al. 
and Anderson et al., (3, 6) rather than the 1:10 dilution recommended by Rahman et al. 
Another notable difference in the methods published by Rahman et al. was the use of 
sodium phosphate buffer with 1 mM EDTA (NaPE), while the Rahman protocol suggested 
potassium phosphate buffer with 5 mM EDTA (KPE). This change was made so that all 
reagents were the same as previously published methods by the C. Outten group (7, 8). The 
combined protocols and changes produced results comparable to published data from the 
lab.  
 
Reagents in this method: 
0.1 M NaPE buffer- 100 mM sodium phosphate, 1 mM EDTA sodium salt, pH 7.5 
1 mM NADPH (prepared in NaPE buffer)- Make fresh and keep out of light  
2 mM DTNB (prepared in NaPE buffer) – Make fresh and keep out of light 
3 U/mL GSSG reductase (GLR) (prepared freshly in NaPE buffer) 
5-sulfosalicylic acid (SSA) 
2-vinylpyridine- do not dilute this product and use under fume hood  




Whole Cell GSH Sample Preparation: 
1. Grow cells in YPD or SC selection media until mid-log phase in desired volume. 
2. Collect 2 x 107 cells (2 mL at 1 O.D.) by spinning at 12000 rpm for 30 s at room 
temperature. This amount is assuming 1 O.D. = 1 x 107 cells. (For gsh1∆ strains 
harvest 2 x 109 cells since [GSH] is low.)  
3. Wash cells twice with water and aspirate off SN. Be careful not to disturb pellet. 
4. Prepare 1 mL 10% 5-sulfosalicylic acid (SSA) by dissolving 100 mg of SSA into 1 
mL of water.  Prepare 5-10 mL 1% SSA depending on amount needed for assays.  
5. Resuspend cells in 50 µL of ice-cold 1% SSA and lyse with approximately 20 µL 
of glass beads in bead beater. (For gsh1∆ strains, use 250 µL of ice-cold 1% SSA 
with 100 µL of glass beads.) 
6. Bring extract to a final volume of 250 µL using ice-cold 1% SSA. (Do not dilute 
gsh1∆ extracts.) 
7. Allow cells to incubate on ice for 30 min. 
8. Spin extract at 13000 x g for 5 min at 4 °C. 
9. Samples can be measured immediately or frozen at -80 °C until ready to assay GSH.  
 
Enzyme Assay Protocol: 
1. Prepare a 100 mM GSH stock solution in NaPE buffer and dilute to 1 mM GSH in 
1% SSA. 
2. Create GSH standards of 0 µM, 1 µM, 2.5 µM, 5 µM, 7.5 µM, 15 µM, and 25 µM 
GSH using 1% SSA by serially diluting each standard from the 1 mM GSH stock. 
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3. Mix equal volumes of freshly prepared DTNB and GLR solutions in a reagent 
reservoir. Keep the reservoir covered with aluminum foil while working with lights 
on.  
4. In a separate reservoir add freshly prepared NADPH solution. Keep covered with 
aluminum foil while working with lights on. 
5. Add 20 µL of the blank, standards, and sample into individual wells of a clear non-
sterile 96-well plate.  
6. Add 120 µL of the DTNB/GLR mixture into each well and pipet up and down to 
mix. 
7. Allow 30 s for the conversion of GSSG to GSH, then add 60 µL of NADPH and 
pipet up and down to mix.  
8. Read the absorbance at 412 nm every 15 s for 2 min.  
 
Preparation of GSSG samples:  
1. Prepare a 50 mM GSSG stock solution in NaPE buffer and dilute to 0.5 mM GSH 
in 1% SSA. 
2. Create GSSG standards of 0 µM, 0.5 µM, 1 µM, 2.5 µM, 5 µM, 7.5 µM, and 12.5 
µM GSH in 1% SSA by serially diluting each standard from the 0.5 mM GSSG 
stock. 
3. Transfer 50 µL of the acidified cell extract into a 1.5 mL Eppendorf tube (for 
mitochondrial samples use 25 µL). 
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4. Add 1 µL 2-vinylpyridine to the 50 µL acidified cell extract and vortex the mixture 
(for mitochondrial samples use 0.5 µL for 25 µL). Use the fume hood when working 
with 2-vinylpyridine. 
5. To the 2-vinylpyridine treated samples add 1 µL of 25% triethanolamine (for 
mitochondrial samples use 0.5 µL). 
6. Incubate under the fume hood for 1 hour at room temperature. 
7. Prepare reagents and read GSSG samples as described above for GSH.  
 
Large Scale Mitochondria Isolation and Purification   
The Large Scale Mitochondria Isolation Protocol described in this dissertation was 
adapted from previously described methods (4, 9). In this protocol, I have outlined details 
about wash and resuspension volumes that worked well. Notes for how to obtain 
mitochondria without ER and vacuole contamination are also included. Unfortunately, our 
data suggested that plasma membrane cannot be completely separated from mitochondria 
via density gradient ultracentrifugation.  
 
Reagents for this method: (sterile filter or autoclave buffers and store at 4 °C): 
Zymolyase buffer: 1.2 M sorbitol, 20 mM potassium phosphate, pH 7.4 
SEM buffer:  250 mM sucrose, 1mM EDTA, 10 mM MOPS-KOH, pH 7.2 (stable 
for 1 month) 
DTT buffer:  100 mM Tris-H2SO4, pH 9.4, 10 mM dithiothreitiol (DTT) (add DTT 
just prior to use) 
129 
 
Homogenization buffer: 0.6 M sorbitol, 10 mM Tris-HCl, pH 7.4, 1 mM EDTA, 
1 mM PMSF, 0.2% BSA (add PMSF from a freshly prepared 100 mM stock in 





Zymolyase 20T (ICN Biochemical): 20 mg/mL in H2O – store at - 20°C. (Note: 
zymolyase works better after stock is stored at -20°C then thawed – NOT freshly 
made) 
 
Sucrose Gradient Buffer 
EM buffer:  1 mM EDTA, 10 mM MOPS-KOH, pH 7.2 (used for making various 
concentrations of sucrose at the mitochondrial purification step) 
 
 Isolation of Crude Mitochondria Fraction Protocol  
1. Patch single colony from freezer stock onto plates and grow at 30 °C until patch is 
thick enough to start overnight cultures. 
2. Grow cells in 100 mL YPG (3% glycerol) or SC (synthetic complete) selection 
media using a 500 mL flask at 30 °C overnight to exponential phase. Mitochondria 
will be more abundant in non-fermentative medium (e.g. glycerol). 
3. The next morning, dilute cells into 1.5 L of media using 5-L flasks to O.D. of 0.03 
(or required O.D.). 
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4. Grow cells until an O.D. of 2 is reached. 
5. Harvest cells at 3000 x g for 5 min at 4 °C.  All centrifugation during the isolation 
of crude mitochondria was done using the Avanti J-E Centrifuge (Consult Dr. 
Wayne Outten’s group for use). 
6. Pre-weigh 50-mL centrifuge tubes. 
7. Pour off SN and resuspend cell pellet in 30 mL H2O. 
8. Spin at 3000 x g for 5 min at 4 °C. Pour off SN. Repeat steps 7 and 8.  
9. Measure net wt. of cell pellet in 50-mL centrifuge tubes. (typical weight is 3-4 g/L) 
10. Resuspend pellet in pre-warmed DTT buffer (2 mL/g cells). Shake at 80 rpm at 30 
°C for 20 min. 
11. Centrifuge cells at 3000 x g for 5 min at 4 °C. 
12. Resuspend the pellet in zymolyase buffer (7 mL/g) without zymolyase. Centrifuge 
at 3000 x g for 5 min at 4 °C. 
13. Resuspend the pellet in zymolyase buffer (7 mL/g). Add 3 mg of zymolyase per g 
of cells.  Shake at 80 rpm at 30 °C for 30-45 min. 
14. Centrifuge cells at 3000 x g for 5 min at 4 °C and remove SN. 
15. Gently wash pellet in zymolyase buffer (7 mL/g). 
16. Centrifuge cells at 3000 x g for 5 min at 4 °C and remove SN. 
17. Resuspend pellet in ice-cold homogenization buffer (6.5 mL/g + 1:100 protease 
inhibitors). Samples should be kept on ice from this step forward to prevent protein 
degradation.   
18. Pestle 15 slow strokes in a pre-chilled homogenizer (use a large Dounce 
homogenizer with loose fitting pestle). 
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19. Add 1 equal volume of homogenization buffer. Spin 5 min at 1500 x g at 4 
°C.  Carefully transfer SN to a new tube (pellet contains unbroken cells and nuclei, 
SN contains crude cytosolic fraction and mitochondria). 
20. Centrifuge the SN at 4000 x g for 5 min at 4 °C. Discard the pellet. 
21. Spin remaining total extract at 12000 x g for 10 min at 4 °C and remove SN. 
22. Resuspend the pellet in ~ 2 mL SEM buffer and centrifuge again at 4000 x g for 5 
min at 4 °C, followed by a second spin of the SN at 12000 x g for 10 min at 4 °C. 
Remove SN. (This step is optional and used to obtain purer mitochondria.)  
23. Gently resuspend pellet (crude mitochondria) in 100 µL of SEM buffer. (Cut 2 mm 
off a yellow tip to avoid disruption of mitochondria.) 
24. Determine the concentration of crude mitochondria. 
25. The sample can be flash frozen in liquid nitrogen and stored at -80 °C. 
Note: Prior to purification, crude mitochondria were placed in a glass-Teflon homogenizer 
and given 10 strokes using a loose pestle. This step was done to ensure that ER and vacuole 
contamination was removed during the purification step. 
 
Purification of Crude Mitochondria Protocol  
1. Prepare sucrose gradient by loading 1.5 mL of 60% sucrose (prepared in EM buffer) 
onto the bottom of ultra-clear centrifuge tubes (Beckman No. 344059). Pipet 
carefully without disturbing the phases in a stepwise manner by adding 4 mL of 
32% sucrose, 1.5 mL of 23% sucrose, and 1.5 mL of 15% sucrose (all prepared in 
EM buffer). Keep tubes in the fridge for at least 2-3 hours before use. (A needle 
syringe was used to create the sucrose gradient.) 
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2. Carefully load the crude mitochondria (0.2 - 1 mL) on top of the sucrose gradient 
immediately before centrifugation step. 
3. Centrifuge for 1 hour at 2 °C at 134000 x g (33000 rpm). The Beckman SW41 Ti 
swinging-bucket rotor was used in during this step. (Consult with Dr. Qian Wang’s 
group about using the ultracentrifuge.) 
4. Recover the purified mitochondria with a Pasteur pipet between the 60% and 32% 
sucrose interface. 
5. If more than one sucrose gradient was needed, pool all mitochondrial samples and 
dilute with 2X volume of SEM buffer. 
6. Pellet the mitochondria using 10000 x g at 4 °C. (Sorvall™ Legend™ Micro 21R 
refrigerated microcentrifuge was used for this step.)  
7. Resuspend the mitochondrial pellet in a small (100-200 µL) volume of SEM and 
determine the concentration. 
8. The sample can be flash frozen in liquid nitrogen and stored at -80 °C. 
 
Extraction of Plasma Membrane Proteins from Whole Cells 
To extract the Hgt1-HA protein out of the plasma membrane of whole cell extracts, 
the lysis buffer listed below was modified from the total cell extract buffer described by 
Aggarwal et al. (10). Cell extracts were made using 150 µL glass beads and 250 µL lysis 
buffer. Samples were lysed by vortexing the sample for one minute and incubating on ice 
for one minute between vortexing. This step was repeated four times. The resulting SN was 




Plasma membrane lysis buffer: 
• 50 mM Tris-CL, pH 7.5 
• 1% sodium deoxycholate 
• 1% Triton-X-100 
•  0.1% sodium dodecyl sulfate 
• 0.05% phenylmethylsulfonyl fluoride (PMSF)  
 
GSH Uptake in Isolated Yeast Mitochondria 
Mitochondrial samples were prepared using the Small Scale Mitochondria Isolation 
Protocol described above. Uptake of GSH was adapted from the protocol described by 
Shen et al. (5). Incubation temperature was adjusted to 30 °C which is conducive for yeast. 
The concentration of GSH added was determined experimentally so that uptake could be 
measured using the GSH/GSSG assay described above. Incubation time was determined 
using data reported by Kumar et al. that showed GSH levels spike within an hour of HGT1 
overexpression strains treated with GSH (11). 
  
Reagents used for this assay: 
SM buffer:  250 mM sucrose, 10 mM MOPS, pH 7.2 (sterile filter or autoclave) 
EM buffer: 1 mM EDTA, 10 mM MOPS-KOH, pH 7.2 
 
27% sucrose: To make 100 mL, dissolve 27 g sucrose in about 70 mL EM buffer; once 





GSH Uptake Protocol: 
1. Make freshly prepared mitochondria according to the Small Scale Mitochondria 
Isolation Protocol. During step 15 do not use protease inhibitors or PMSF, because 
mitochondria will be used for the GSH/GSSG assay. 
2. Resuspend mitochondria in 1/5 of the total extract volume using SM buffer and 
take the protein concentration via the standard Bradford assay. 
3. Resuspend the mitochondria in 1.5 micro-centrifuge tubes at 2 mg/mL and treat 
with 15 mM GSH prepared in SM buffer. 
4. Using a needle syringe, pipette 250 µL of 27% sucrose under the mitochondria 
slowly, creating a cushion. 
5. Place the tubes in the 30 °C incubator for 30 min to allow GSH uptake into 
mitochondria. 
6. Centrifuge mitochondria through the sucrose cushion at 14000 x g for 10 min at 4 
°C. 
7. Aspirate off the SN and wash mitochondria very carefully with 500 µL SM. 
8. Centrifuge at 14000 x g for 10 min at 4 °C. 
9. Aspirate off the SN and add 50 µL of 1% SSA. 
10. Incubate on ice for 30 min. 
11. Spin 5 min at 13000 x g and transfer to new tube. 





Chromosomal Replacement- Cloning of the GSH1 Deletion Plasmid  
Creation of the GSH1 deletion plasmid (pGSH1KO) was prepared using 
integrating plasmid vectors pRS403 and pRS406. Upstream and downstream 
regions of the GSH1 gene were cloned into the empty vectors using standard 
cloning procedures. The resulting yeast integrating plasmids were linearized with 
EcoRI prior to transformation into yeast (Fig 5.1). GSH1 is knocked out of strains 
containing pGSH1KO via homologous recombination.   
 
 
1. Choose an empty vector with the selection marker of choice and look for restriction 
enzyme sites in the vector that can be used for cloning in fragments. (The upstream 
and downstream regions of the GSH1 gene was cloned into the pRS403 and pRS406 
vectors at the BamHI and SalI sites). 
2. Create primers to amplify the upstream and downstream regions of GSH1 that will 
include portions of the gene. In the case of pGSH1KO, restriction enzymes sites 
were engineered into the primers so the two PCR fragments are ligated together  
with EcoRI and cloned into the vector with BamHI and SalI (see Chapter 3 for 
primer sequences).  
3. Ligate both the upstream and downstream PCR fragments into the yeast integrating 
plasmid containing an amino acid selectable marker using T4 DNA Ligase (NEB) 
at 16 °C overnight or at room temperature with various ratios of vector to fragments. 
Transform the ligation reactions into DH5α cells using 10 µL of each reaction ratio 







Figure 5.1 Diagram of steps for creating the pGSH1KO plasmid. This illustration 
represents the PCR products and ligation into the empty vector pRS403 by engineering 
restriction sites into primers. The subsequent digestion and integration in the yeast genome 
is also depicted. 
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creating the GSH1 deletion plasmid since the pRS403/406 vectors confer ampicillin 
resistance)  
4. Confirm formation of the correct deletion plasmid by restriction mapping and DNA 
sequencing.  
5. Linearize the yeast integrating plasmid overnight at 37 °C via restriction enzyme 
digest. (EcoRI restriction digest was performed on the GSH1 deletion plasmid) 
6. After linearization, the integrating deletion plasmid can be inserted into the genome 
of yeast strains via homologous recombination using standard lithium acetate 
transformation protocols.  
7. GSH1 deletion can be confirmed via PCR colony screening, GSH assay, and Gsh1 
western blot analysis.  
 
Growth Curve Assay- Synergy H1 Plate reader  
Yeast cell growth was analyzed using a Synergy H1 plate reader. The 
manufacturer’s instructions were followed to establish the protocol. The procedure 
outlined below details the assay and subsequent analysis of growth. We found that yeast 
started at O.D. lower than 0.05 could not be detected. Thus, all strains grown using this 
method were blank corrected from cells started at O.D. = 0.05 (12, 13). 
 
Procedure:  




2. Resuspend a loopful of cells into 1 mL of sterile water and take O.D. in a clear 96 
well plate using the plate reader. (This 96-well plate does not have to sterile)  
3. After taking the O.D., dilute each strain to 0.5 O.D.  in new sterile micro- centrifuge 
tubes. 
4. Add 20 µL of the 0.5 O.D. of cell stock into a sterile flat bottomed clear 96-well 
microplate (Corning 96-well plates, catalog number 3596 were used in this study)  
5. To the cells, add 180 µL of autoclaved media so that the starter O.D.  is 0.05 
(starting cells at O.D. of less than 0.05 is difficult to detect using this method and 
may yield negative values when subtracted from blank)   
6. Leaving the clear plastic top off, seal the top of the 96-well plate with a clear 
membrane. This allows cells to have aeration during growth while reducing 
contamination and evaporation. (The Breath Easy sealing membranes from Sigma-
Aldrich (catalog # Z380059) were used for all growth curves)  
7. Place sealed 96-well plate in the plate reader without the lid. 
8. Select wells to be read in the procedure and plate layout sections. (The software 
used for this experiment is Gene5 2.09.) 
9. Allow temperature to reach 30 °C before taking initial readings. Measurements 
were taken every 30 min with the continuous orbital shaking mode set over a course 
of 24 hrs. The shaking speed was set to slow and frequency set at 559 (1 mm 
amplitude.  
10. Analyze growth curves by plotting the blank corrected OD600 values of each strain 
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